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Lauren Marie Rudolph 
MECHANISMS OF ESTROGEN-DEPENDENT DENDROGENESIS IN MOTONEURONS OF 
THE SPINAL NUCLEUS OF THE BULBOCAVERNOSUS 
Early hormone exposure is required for the development of many neural structures 
across a variety of species.  The spinal nucleus of the bulbocavernosus (SNB), a motor nucleus 
that controls erections and ejaculations in male rats, requires gonadal hormones for typical 
development.  While the masculinization of many features of the SNB neuromuscular system is 
androgen-dependent, dendrogenesis requires estrogens during a developmentally restricted 
critical period.  This estrogen-dependent SNB dendrite growth is mediated by estrogen receptors 
(ERs) in the SNB target musculature (the bulbocavernosus, BC).  I have demonstrated that ERα 
expression in BC extra-muscle fiber cells defines the critical period for estrogen-dependent SNB 
dendrite growth, and estradiol treatment during ERα expression in these extra-muscle fiber cells 
fully masculinizes SNB dendrites.  Further, BC ERα expression is sensitive to gonadal hormones: 
Castration dramatically upregulates the density of extra-muscle fiber cell ERα.  Brief estradiol 
treatment during heightened ERα expression results in rapid, robust dendritic growth, suggesting 
that the estrogen sensitivity of SNB dendrites is determined by ERα levels in the target 
musculature.  I have shown that the castration-induced increase of ERα in the BC extends the 
critical period for estrogen-dependent SNB dendrogenesis, the first demonstration that SNB 
dendrites respond to estrogens outside the early postnatal period.  I have shown that brain-
derived neurotrophic factor (BDNF) is upregulated in the SNB target muscle following early 
postnatal castration, but immunolabeling for BDNF in SNB somata does not change.  In both 
cases, estradiol treatment does not affect BDNF levels, demonstrating that while there may be a 
role for BDNF in early dendrite growth, estrogen-dependent dendrogenesis is not mediated by 
BDNF.  Finally, I have shown that the ERα-expressing extra-muscle fiber cells in the BC are not 
satellite cells, and the specific cell type mediating early estrogen-dependent dendritic growth 
remains unknown.  Together, these results elucidate the mechanisms of estrogen-dependent 
dendrite development in the SNB of male rats, establish the basis for the estrogen-sensitive 
critical period, and demonstrate the plasticity of estrogen-mediated dendrogenesis in the SNB. 
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CHAPTER 1: Introduction
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The lumbar spinal cord of rats contains a sexually dimorphic nucleus, the spinal nucleus 
of the bulbocavernosus (SNB), also known as the dorsomedial nucleus (DM; Schrøder, 1980).  In 
male rats, the SNB consists of ~200 motoneurons that innervate the perineal muscles 
bulbocavernosus (BC), levator ani (LA) and the anal sphincter (Breedlove and Arnold, 1980; 
Schrøder, 1980; McKenna and Nadelhaft, 1986; Fig. 1.1).  The BC/LA muscles attach to the base 
of the penis, and are necessary for successful copulation and insemination (Sachs, 1982; Hart 
and Melese-D'Hospital, 1983).  In female rats, the perineal musculature is absent or greatly 
reduced and the SNB consists of ~60 motoneurons that predominantly innervate the external 
anal sphincter (Hayes, 1965; Čihák et al., 1970; McKenna and Nadelhaft, 1986; Tobin and 
Joubert, 1991).  The morphology of SNB motoneurons is also sexually dimorphic, and SNB 
somata of adult females are typically half as large as those of adult males (Breedlove and Arnold, 
1981; McKenna and Nadelhaft, 1986). 
The dimorphisms in the SNB neuromuscular system result from the actions of gonadal 
steroids, operating both developmentally and in adulthood.  During perinatal development, 
androgens are responsible for the prevention of normally occurring motoneuron death (Nordeen 
et al., 1985), somal growth (Lee et al., 1989; Goldstein et al., 1990; Goldstein and Sengelaub, 
1992), perineal musculature retention (Čihák et al., 1970), and neuromuscular synapse 
elimination (Jordan et al., 1989a; Jordan et al., 1989b).  Conversion of testosterone to estrogenic 
metabolites does not appear to be involved in this regulation, and treatment with estradiol has no 
effect on SNB motoneuron survival (Breedlove et al., 1982; Goldstein et al., 1990), somal growth 
(Breedlove et al., 1982; Goldstein and Sengelaub, 1994; Burke et al., 1997; Hebbeler et al., 
2002), target muscle retention (Breedlove et al., 1982; Burke et al., 1997), or neuromuscular 
synapse elimination (Jordan et al., 1995). 
Conversely, dendritic development in the SNB is regulated by both androgens and 
estrogens.  During normal development, SNB dendrites grow profusely during the first 4 postnatal 
weeks (Goldstein et al., 1990).  This growth is steroid-dependent: In males castrated 7 days after 
birth, dendrites fail to grow beyond their precastration lengths, whereas dendritic lengths of  
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Figure 1.1.  Schematic transverse section of lumbar spinal cord of the male rat.  Motoneurons of 
the spinal nucleus of the bulbocavernosus (SNB) are located medially.  These motoneurons 
innervate the bulbocavernosus and levator ani (BC/LA) muscles that attach to the base of the 
penis and are involved in erections in ejaculation.  Other major motor nuclei present in lumbar 
spinal cord include the sexually dimorphic dorsolateral nucleus (DLN) that innervates the 
ischiocavernosus muscle, and the sexually monomorphic retrodorsolateral nucleus (RDLN) that 
innervates the extensor digitorum longus muscle of the foot.  
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castrated males receiving testosterone replacement are not different from those of intact males 
by 4 weeks of age (Goldstein et al., 1990).  Treatment with either of testosterone’s metabolites, 
dihydrotestosterone or estradiol, partially supports dendritic growth (Goldstein and Sengelaub 
1994), but combined treatment with both metabolites is as effective as testosterone in fully 
supporting dendritic growth (Goldstein and Sengelaub, 1994).  Estrogenic support of postnatal 
dendritic growth appears to be mediated by estrogen action at the neuromuscular periphery, as 
local blockade of estrogen receptors (ERs) with tamoxifen implants at the SNB target 
musculature during the period of dendritic growth results in significantly decreased dendritic 
lengths, but placing identical implants at the scapula has no effect on SNB dendritic growth 
(Nowacek and Sengelaub, 2006).  Conversely, treatment with estradiol muscle implants in 
castrates supports dendritic growth through postnatal day 28, demonstrating that estradiol action 
at the periphery during the early postnatal period is critical for SNB dendrite growth (Nowacek 
and Sengelaub, 2006).  This estrogenic support of SNB dendrites is transient, restricted to the 
early postnatal period: by the seventh week of age, dendritic lengths in estradiol-treated castrates 
are not different from those in oil-treated castrates, and are shorter than those of castrates 
treated with either testosterone or dihydrotestosterone (Goldstein and Sengelaub, 1994).  In 
adulthood, SNB dendritic lengths in castrates can be fully maintained with dihydrotestosterone or 
testosterone, but estradiol is completely ineffective in supporting dendritic morphology 
(Verhovshek et al., 2010b).  Chapter 2 of this dissertation addresses why estrogen-dependent 
dendrite growth mediated through ERs in the SNB target muscle is transient, by assessing ERα 
immunolabeling in the BC muscle during the estrogen-sensitive period, and outside of it.  
Experiments from Chapter 2 also address the timing of estrogen treatment in relation to ERα 
levels in the BC muscle, and how this relates to estrogen-dependent dendrite growth during the 
early postnatal period.  Chapters 3 and 4 build upon the results of Chapter 2 experiments and 
assess the influence of gonadal hormones on ERα in the BC muscle, and how changes in 
peripheral ERα density affects the potential for SNB motoneuron dendrites to grow in response to 
estrogen treatment, both during and outside of the critical period for estrogen-dependent 
dendrogenesis that occurs during early postnatal life in male rats. 
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The early chapters of this thesis are focused on elucidating the developmental profile of 
ERα in the SNB target muscle and how this expression profile relates to the critical period for 
estrogen-dependent SNB dendrogenesis; the later Chapters are focused on the potential 
molecular mechanisms that control estrogen-dependent SNB dendrite growth.  The experiment in 
Chapter 5 assesses ERα expression in a non-muscle fiber cell type in the SNB target muscle, to 
better understand the nature of ERα expression in the SNB target muscle during the early 
postnatal period.  The goal of Chapter 6 is to further elucidate the molecular mechanisms of SNB 
dendrite growth in response to estrogens during early development.  We do not know the 
pathways downstream of ER activation in the BC muscle that control estrogen-dependent 
dendrite growth.  However, the molecular mechanisms of androgen-dependent influences on 
SNB dendrites in adulthood have been investigated and involve brain-derived neurotrophic factor 
(BDNF), so it is possible that similar mechanisms underlying the maintenance of androgen-
dependent of adult SNB motoneuron morphology also control estrogen-dependent changes in 
SNB motoneurons during development. 
Gonadal hormone regulation of BDNF and BDNF-androgen interactions maintain SNB 
morphology in adulthood (for review, see Verhovshek et al., 2012).  BDNF mRNA and protein are 
decreased in SNB somata and proximal dendrites after castration in adulthood, and testosterone 
treatment restores this castration-induced reduction in SNB motoneuron BDNF (Ottem et al., 
2007; Verhovshek et al., 2010a).  Conversely, in the SNB target musculature, adult castration 
results in an increase in BDNF expression, and testosterone treatment returns BDNF to its 
precastration levels (Verhovshek et al., 2010a).  The castration-induced increase in muscle BDNF 
and decrease in SNB motoneuron BDNF could reflect a decrease in retrograde transport of 
BDNF from the BC/LA to SNB motoneurons or an increase in peripheral BDNF production in the 
absence of gonadal hormones.  Regardless of the mechanism, the castration-induced increase in 
muscle BDNF coincides with SNB muscle, somal, and dendritic atrophy.  Given that the SNB 
target musculature is the site of action for the maintenance of SNB morphology by gonadal 
hormones, and a site of androgenic regulation of BDNF in SNB somata, these data suggest that 
heightened BDNF levels in the muscle could be mediating the castration-induced atrophy in the 
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SNB system.  Blockade of ARs at the SNB target muscle reduces BDNF expression in 
motoneurons, and local testosterone treatment restores the castration-induced decrease in BDNF 
levels in SNB somata (Verhovshek and Sengelaub, 2013). 
Interrupting BDNF signaling using trkB IgG affects SNB motoneuron morphology, and 
appears to promote dendrogenesis.  SNB dendritic arbors of both castrated and intact males 
hypertrophy when BDNF is blocked, resulting in dendrite lengths that are longer than those of 
intact control animals.  Similarly, blocking BDNF signaling prevents castration-induced SNB 
somal atrophy (Verhovshek and Sengelaub, 2010b).  Additionally, BDNF has also been 
implicated in the perinatal masculinization of SNB motoneuron number.  Treating animals with 
trkB IgG blocks the androgen-induced prevention of SNB cell death, suggesting that androgen-
BDNF interactions also play a role in hormone-mediated masculinization of the SNB during early 
development (Xu et al., 2001).  Together, these data demonstrate that BDNF expression in SNB 
motoneurons and their target musculature are regulated by gonadal hormones, and BDNF 
signaling plays a role in the development and maintenance of SNB morphology. 
In addition to BDNF as a critical player in SNB morphology in adulthood, there are 
examples of estrogen-induced BDNF regulated of morphology across the neuraxis.  The Bdnf 
gene contains an estrogen response element (Sohrabji et al., 1995), providing a direct 
mechanism for estrogenic regulation of BDNF transcription.  In neonatal mice, estradiol treatment 
increases BDNF levels and stimulates dendritic spino- and synaptogenesis in the cerebellar 
Purkinje cells (Sasahara et al., 2007). Estradiol-induced upregulation of BDNF is blocked by the 
ER antagonist tamoxifen, demonstrating that ERs mediate the estrogenic regulation of BDNF in 
these cells.  Estradiol has been shown to promote dendrite growth by either increasing (Krizsan-
Agbas et al.,2003) or decreasing (Murphy et al., 1998) BDNF levels, demonstrating that estradiol-
dependent dendrite growth is mediated by changes in BDNF signaling in other systems and 
BDNF could be an estrogen-regulated molecule that affects developmental dendrite growth in the 
SNB.  During early postnatal development, castration results in an increase in BDNF protein in 
the hippocampi of male rats, and estrogen treatment of castrates decreases BDNF to 
precastration levels (Solum and Handa, 2002).   These data suggest that estrogen acts to repress 
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BDNF expression during early development in rat hippocampus both in vitro and in vivo, 
potentially through receptor-mediated pathway, as ERα and BDNF are coexpressed in these 
hippocampal neurons (Solum and Handa, 2002).  This suggests ERα is the potential site of action 
for estrogenic regulation of BDNF in these neurons, as ERβ-BDNF colocalization does not occur 
in these cells.  These data suggest that estrogen can regulate BDNF in the same manner as 
androgens in the SNB system, and demonstrate that estrogen-dependent dendrite growth could 
be mediated by changes in muscle BDNF.  The experiments of Chapter 6 are designed to 
determine if BDNF is involved in estrogen-dependent SNB dendrite growth during the early 
postnatal period, using immunohistochemistry and enzyme-linked immunoassay (ELISA) 
techniques to measure BDNF in both the peripheral and central components of the SNB 
neuromuscular system after castration and estradiol treatment. 
Together, the experiments of this dissertation focus on understanding how estrogen-
dependent SNB dendrite growth occurs, and why there is a developmental critical period for this 
form of SNB dendrogenesis, and what mechanisms underlie this transient, estrogen-mediated 
dendrite growth in a typically estrogen-insensitive neuromuscular system.  The following 
experiments and resultant data describe mechanisms of estrogen-dependent dendritic growth in 
the SNB neuromuscular system and provide insight into how hormone-directed sexual 
differentiation proceeds in sexually dimorphic structures within the mammalian nervous system. 
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CHAPTER 2:  Rudolph, L.M. & Sengelaub, D.R. (2013). Critical period for estrogen-dependent 
motoneuron dendrite growth is coincident with ERα expression in target musculature.  
Developmental Neurobiology. 73(1): 72-84. 
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BACKGROUND 
Because estrogen-dependent SNB dendrite growth is transient and mediated by estrogen 
action at ERs in the target musculature, we hypothesized that the developmentally restricted 
estrogen-dependent SNB dendrite growth was mediated by a change in ER expression at the 
target musculature.  In Experiment 1, we used immunohistochemistry to assess ERα labeling in 
the BC muscle throughout the period of estrogen-dependent SNB dendrogenesis, and later in 
postnatal development and in adulthood, when SNB dendrites are insensitive to estrogens.  Basal 
lamina immunolabeling was quantified in the same ERα-labeled tissue sections to determine the 
location of ERα label in relation to muscle fibers (identified by basal lamina immunolabeling). 
 
Experiment 1 
MATERIALS AND METHODS 
Animals.  Untimed pregnant rat dams (Sprague-Dawley, Harlan, Indianapolis, IN) were 
maintained on a 12-h light, 12-h dark cycle, with unlimited access to food and water.  When 
pregnant females gave birth (day of birth = P1), pups were sexed and litters culled when 
necessary, with preference for males over females.  Males were killed weekly from P7 to P49, 
and in adulthood (approximately 100 d old); overall n = 40 (P7, n = 6; P14, n = 6; P21, n = 6; P28, 
n = 6; P35, n = 4; P42, n = 3; P49, n = 3; adult, n = 6).  All procedures were carried out in 
accordance with the NIH Guide for the Care and Use of Laboratory Animals and approved by the 
Bloomington Institutional Animal Care and Use Committee. 
Immunohistochemistry.  Animals were weighed, overdosed with urethane (0.25 g/100 g of body 
weight), and perfused transcardially with saline followed by cold 4% paraformaldehyde in 0.1M 
phosphate buffer (pH = 7.4).  The BC/LA muscles were removed and postfixed in the same 
fixative for 24 h and transferred to 30% sucrose in 0.1M phosphate buffer for a minimum of 24 h 
of cryoprotection.  The BC/LA was cut horizontally into 12 μm sections on a cryostat at -16°C.  
Sections were thaw-mounted onto gelatin-coated slides, and stored at -16°C.  For 
immunohistochemical processing, slides were brought to room temperature, removed from the 
slide boxes, placed in a glass staining rack and rinsed 3 x 5 min in phosphate buffered saline 
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(PBS, pH 7.4).  After rinsing, a hydrophobic border (Super Pap Pen, Ted Pella, Inc., Redding, 
CA) was created around each tissue section, and the first incubation did not occur until the border 
had dried (about 3 min).  All incubations occurred in a humidified chamber and were performed 
by pipetting 200 μl of solution onto each section. 
Sections were incubated for 45 min at room temperature in blocking solution containing 
10% normal goat serum (NGS; Vector Laboratories, Inc., Burlingame, CA) and 0.2% Triton X-100 
in PBS.  Sections were then incubated for 48 h at 4ºC in 4% NGS in PBS containing an antibody 
directed against the last 14 amino acids of the rat ERα (C1355, 1:1000; Millipore, Temecula, CA).  
After primary ERα incubation, sections were rinsed 3 x 5 times in PBS and incubated for 2 h at 
room temperature in 4% NGS in PBS containing a conjugated secondary antibody (goat anti-
rabbit Alexa Fluor 488 F(ab’)2 fragments (H+L), 1:200; Invitrogen, Eugene, OR).  Sections were 
then rinsed 3 x 5 min in PBS, and incubated in a 4% NGS in PBS solution containing a mouse 
monoclonal antibody for basal lamina (D18 supernatant, 1:50; Developmental Studies Hybridoma 
Bank, Iowa City, IA) for 12-18 h at 4°C.  Following this incubation, sections were rinsed 3 x 5 
times in PBS and incubated for 2 h at room temperature in a secondary antibody (goat anti-
mouse IgG-TRITC, 1:200; Sigma-Aldrich, Oakville, Ontario, Canada).  Sections were then rinsed 
3 x 5 min in PBS, briefly air dried, and coverslipped with aqueous mounting fluid (Vectashield 
HardSet Mounting Medium; Vector Laboratories, Inc.).  After slides dried for 5 min at room 
temperature, they were sealed with nail polish, dried for 10 min at room temperature, laid flat to 
dry overnight at 4°C, and then stored at 4°C.  To control for nonspecific staining, control sections 
incubated without both primary antibodies were generated and demonstrated no immunostaining. 
Microscopic Analysis.  Because all of our previous developmental work on SNB motoneuron 
dendritic growth, hormone sensitivity, and critical period effects were done in BC-projecting 
motoneurons, our analysis was restricted to the BC muscle.  After slides were brought to room 
temperature, sections of muscle were first viewed at 150-350X magnification under epifluorescent 
illumination to visualize basal lamina staining.  The BC is a relatively complex muscle, with 
muscle fibers traveling in several different directions, resulting in fields containing both cross- and 
longitudinally sectioned muscle fibers (Fargo et al., 2003); fields containing large numbers of 
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basal lamina-stained muscle fibers in cross-section were selected for analysis.  Because cross-
sectional muscle fiber size varied across ages, variable magnifications and sampling frames were 
employed.  After locating areas of tissue that contained sufficient numbers of cross-sectioned 
muscle fibers, magnification was increased until the field of view contained a minimum of 14 
fibers, resulting in a final magnification of at least 1450X.  Using Stereo Investigator (MBF 
Bioscience, Inc., Williston, VT), muscle fibers were sampled systematically, by either analyzing all 
fibers in a field of view or superimposing a grid on the tissue image (e.g., 100 µm x 100 µm 
square frame) and sampling all fibers within the frame. 
To quantify ERα immunostaining, muscle fibers were visualized under FITC fluorescence 
and images were captured for subsequent analysis.  Areas that appeared to be labeled relative to 
background (see below) were identified as either in-fiber or extra-fiber depending on the location 
of ERα label relative to the basal lamina stain.  One field per section and 1-3 sections per animal 
were analyzed; overall, an average 69.40 muscle fibers per animal were traced.  For each 
analyzed tissue section, the mean and standard deviation of muscle fiber FITC luminance values 
were calculated and a minimum labeling criterion of the mean plus two standard deviations was 
established for each section.  Cells that exceeded this criterion were identified as ERα-positive 
and were categorized as either ERα-positive muscle fibers (if surrounded by a basal lamina) or 
ERα-positive extra-muscle fiber cells.  Because muscle fiber area increases with age (potentially 
decreasing the density of immunolabeled muscle fibers), we sampled equivalent numbers of 
muscle fibers across ages and expressed ERα-positive muscle fibers as a percentage of the 
sample.  ERα-positive extra-muscle fiber cells were identified only on the basis of ERα labeling, 
so these numbers were expressed as a density per unit area.  The percentage of ERα-positive 
muscle fibers and density of ERα-positive extra-muscle fiber cells per section were analyzed 
using one-way ANOVAs with Fisher’s LSD post-hoc tests.  Differences were considered 
significant if p < 0.05. 
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RESULTS 
ERα immunolabeling was present in the BC muscle at all ages examined.  
Immunolabeling in muscle fibers was not restricted to nuclei, suggesting cytosolic localization.  
ERα immunolabeling was categorized as either ERα-positive muscle fibers (label contained within 
the basal lamina stain) or ERα-positive extra-muscle fiber cells (label outside basal lamina stain; 
Fig. 2.1).  The average number of muscle fibers analyzed per animal did not differ across ages 
[F(7, 32) = 1.21, n.s.].  For each animal, the number of labeled muscle fibers was expressed as a 
percentage of total muscle fibers sampled.  The percentage of ERα-positive muscle fibers did not 
vary with age [mean = 7.01% ± 0.89; F(7, 32) = 2.20, n.s.]. 
There was a significant main effect of age on the density of ERα-positive extra-muscle 
fiber cells [F(7, 32) = 2.32, p < 0.05; Fig. 2.2].  ERα-positive extra-muscle fiber cells were 
abundant at P7 (209.3 ± 102.8 per mm
2
) and P14 (285.2 ± 115.1 per mm
2
) compared to adult 
levels (LSDs, ps < 0.05). At P21, the density of ERα-positive extra-muscle fiber cells was 
decreased by 38%, and continued to decline into adulthood (0.00 ± 0.0 per mm
2
).  The densities 
of ERα-positive extra-muscle fiber cells after P21 did not differ significantly from adult levels 
(LSDs, n.s.). 
 
Experiment 2 
In Experiment 1, we found that the density of ERα-positive BC extra-muscle fiber cells 
decreased significantly after P21.  Based on these results, we hypothesized that BC extra-muscle 
fiber cells are the site of estrogenic action in supporting SNB dendrite growth, and that the 
transient expression of ERα within BC extra-muscle fiber cells during the early postnatal period 
could define the critical period for estrogen-dependent SNB dendrite growth.  To test this 
hypothesis, in Experiment 2, we castrated males and treated them with estradiol via BC muscle 
implants from P7 to P21, and assessed SNB dendritic morphology at P28, the day at which SNB 
dendrites normally reach maximal length (Goldstein et al., 1990). 
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Figure 2.1.  Digital light micrographs of cross-sections of BC muscle in P14 (top row) with higher 
magnification views of indicated areas (middle row), and adult males (bottom row).  Each row 
shows the same tissue section viewed under different epifluorescent illumination, demonstrating 
immunolabeling for basal lamina only (red; left), ERα only (green; middle), and the merged image 
showing combined basal lamina and ERα immunolabeling (right).  Arrows indicate ERα-positive 
muscle fibers (open arrows) and ERα-positive extra-muscle fiber cells (white arrows); note the 
absence of basal lamina staining of the indicated extra-muscle fiber cell in the middle row.  Scale 
bars = 25 µm.  
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Figure 2.2.  The number of ERα-positive extra-muscle fiber cells per mm
2
 in the BC at P7, P14, 
P21, P28, P35, P42, 49, and in adulthood.  Bar heights represent means ± SEM for three to six 
animals per group.  Asterisk denotes significantly different from adult animals.
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MATERIALS AND METHODS 
Animals. Untimed pregnant rat dams (Sprague-Dawley; Harlan) were maintained on a 12-h light, 
12-h dark cycle, with free access to food and water. Litters were culled to eight pups when 
necessary, retaining males preferentially.  Males were bilaterally castrated under isoflurane 
anesthesia at P7, and were given estradiol implants (see below) at the left BC muscle or were 
untreated (n = 7).  In estradiol-treated castrated males, some implants were removed at P21 (n = 
6), and in other animals, implants remained until P28 (n = 5).  Age-matched intact control males 
(n = 5) were also used (overall n = 23).  All procedures were carried out in accordance with the 
NIH Guide for the Care and Use of Laboratory Animals and approved by the Bloomington 
Institutional Animal Care and Use Committee. 
Implants.  To restrict estradiol treatment to the target musculature, we used our previous method 
(Nowacek and Sengelaub, 2006) to deliver hormones locally to the BC muscle.  This treatment 
produces alterations in motoneuron morphology that can be directly ascribed to local rather than 
systemic effects; furthermore, the treatment has no effect on the normal development of either 
the BC muscle or SNB motoneurons, and no effect on dendritic labeling or tracer transport 
(Nowacek and Sengelaub, 2006).  Small (0.85 mm
3
) implants impregnated with estradiol 
(Steraloids, Newport, RI) were constructed by mixing crystalline estradiol with Silastic adhesive 
(Dow-Corning, Auburn, MI) and compressing the mixture between two glass slides (lightly 
greased with petroleum jelly) separated by a spacer (0.85 mm thick), and allowed to cure.  The 
cured Silastic was cut into 1 x 1 mm pieces (total volume 0.85 mm
3
) and coated on five sides with 
acrylic.  The amount of estradiol in each implant (0.1 mg) was identical to that used previously; 
this dosage does not produce systemic effects, and supports SNB dendritic growth. 
Histochemistry.  Horseradish peroxidase conjugated to the cholera toxin β subunit (BHRP; List 
Biological, Campbell, CA) was used to retrogradely label SNB motoneurons innervating the BC 
muscle.  Previous studies have demonstrated that BHRP labeling permits sensitive detection and 
quantitative analysis of SNB somal and dendritic morphologies (Kurz et al., 1986; Goldstein and 
Sengelaub, 1990; Hebbeler and Sengelaub, 2003).  SNB motoneuron morphology was examined 
at P28 (when SNB dendritic length is normally maximal; Goldstein et al., 1990).  At P26, animals 
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were anesthetized with isoflurane, the perineal muscles exposed, and BHRP unilaterally injected 
(0.5 µl; 0.2% solution) into the left BC muscle, the same muscle for those males that received 
muscle implants.  Forty-eight h after BHRP injection, a period that ensures optimal labeling of 
SNB motoneurons (Kurz et al., 1986; Goldstein et al., 1990), animals were overdosed with 
urethane (0.25 g/100 g body weight) and perfused intracardially with saline followed by cold 1% 
paraformaldehyde/1.25% glutaraldehyde fixative.  Lumbar cords from all animals were removed, 
postfixed in the same fixative for 5 h, and transferred to sucrose phosphate buffer (10% w/v, pH = 
7.4) overnight for cryoprotection.  Spinal cords were then embedded in gelatin, frozen, and 
sectioned transversely at 40 µm; all sections were collected into four alternate series.  For 
visualization of BHRP, the tissue was immediately reacted using a modified tetramethyl benzidine 
protocol (TMB; Mesulam, 1982), mounted on gelatin-coated slides, counterstained with thionin, 
and cover-slipped with Permount.  BC/LA muscles were removed at perfusion and weighed to 
evaluate potential treatment effects on gross muscle development. 
Motoneuron Somata.  The number of BHRP-filled motoneurons was assessed in all sections 
through the entire rostrocaudal extent of the SNB for all animals.  Counts of labeled motoneurons 
in the SNB were made under brightfield illumination, where somata and nuclei could be visualized 
and cytoplasmic inclusion of BHRP reaction product confirmed.  Estimates of the total number of 
labeled SNB motoneurons were obtained using the optical dissector method outlined by 
Coggeshall (1992) and a procedure similar to that of West and Gunderson (1990).  This method 
yields an unbiased count of SNB motoneurons (Raouf et al., 2000).  Counts were made at 500X; 
motoneuron somata could be easily visualized in multiple focal planes. BHRP-labeled 
motoneurons were counted as their somata first appeared in focus while focusing through the z 
axis, and labeled somata in the first focal plane (i.e., “tops”) were not counted.  For each animal, 
counts were derived from sections spaced at 160 µm intervals uniformly distributed through the 
entire rostrocaudal extent of the SNB. Within each section, all labeled somata within the SNB 
were counted.  Estimates of the total number of labeled SNB motoneurons were then obtained by 
correcting for percentage of the tissue sampled. 
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The cross-sectional soma area of BHRP-labeled motoneurons was measured in an 
average of 21.8 motoneurons for each animal using a video-based morphometry system (Stereo 
Investigator; MBF Bioscience, Inc.) at a final magnification of 1350X.  Soma areas within each 
animal were averaged for statistical analysis.  The optical density of labeled somata was also 
measured under brightfield illumination to confirm equivalence of BHRP labeling density. 
Dendritic Length.  For each animal, dendritic lengths in a single representative set of alternate 
sections were measured under darkfield illumination.  Beginning with the first section in which 
BHRP-labeled fibers were present, labeling through the entire rostrocaudal extent of the SNB 
dendritic field was assessed in every other section (320 µm apart) in three dimensions using a 
computer-based morphometry system (Neurolucida; MBF Bioscience, Inc.; final magnification 
250X) to yield both composite illustrations of the arbor and measurements of individual fiber 
lengths.  All BHRP-labeled fibers were drawn regardless of location, size, or contiguity with 
labeled cell bodies to ensure a complete assessment of dendritic length.  Because the entire 
rostrocaudal range of the SNB dendritic field in each animal was sampled, this method allows for 
a complete assessment of SNB dendrites in both the transverse and horizontal planes.  Average 
dendritic arbor per labeled motoneuron was estimated by summing the measured dendritic 
lengths of the series of sections, multiplying by two to correct for sampling, then dividing by the 
total number of labeled motoneurons in that series.  This method does not attempt to assess the 
actual total dendritic length of labeled motoneurons (Kurz et al., 1991), but has been shown to be 
a sensitive and reliable indicator of changes in dendritic morphology in normal development 
(Goldstein et al., 1990), after hormonal or surgical manipulation (Kurz et al., 1986; Goldstein et 
al., 1990; Kurz et al., 1991; Goldstein and Sengelaub, 1994; Goldstein et al., 1996; Hays et al., 
1996; Hebbeler and Sengelaub, 2003), due to dendritic interactions (Goldstein et al., 1993), or 
after NMDA receptor blockade (Hebbeler et al., 2002). 
To assess potential redistributions of dendrites across treatment groups, for each animal 
the composite dendritic arbor created in the length analysis was divided using a set of axes 
radially oriented around the central canal, dividing the spinal cord into 12 bins of 30° each.  The 
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portion of each animal’s dendritic arbor per labeled motoneuron contained within each location 
was then determined. 
Dendritic Extent.  The comparability of BHRP labeling across groups was assessed by 
quantifying both the rostrocaudal and radial dendritic extent of SNB arbors.  The rostrocaudal 
extent of the dendritic arbor was determined by recording the distance between the first and last 
section in which labeled SNB dendrites were present for each animal. In the transverse plane, for 
each animal the maximal radial extent of the dendritic arbor for each section throughout the 
rostrocaudal extent of the SNB dendritic field was measured using the same set of axes and 30° 
bins used for the dendritic distribution analysis.  For each bin, the distance between the central 
canal and the most distal BHRP-filled process was measured. 
Statistical analysis consisted of analyses of variance (one- or two-way with repeated 
measures) followed by appropriate planned comparisons (Fisher’s Protected LSD) as described 
below.  Digital light micrographs were obtained using an MDS 290 digital camera system 
(Eastman Kodak Company, Rochester, NY).  Brightness and contrast of these images were 
adjusted in Adobe PhotoShop (Adobe Systems, Inc., San Jose, CA). 
 
RESULTS 
BC/LA Muscle Weight.  BC/LA muscle weights did not differ across groups [F(3,16) = 1.87, n.s.; 
intact control males = 0.091 ± 0.01 g, castrates = 0.094 ± 0.01 g, castrates treated with estradiol 
implants from P7-P21 = 0.073 ± 0.02 g, castrates treated with estradiol implants from P7-P28 = 
0.077 ± 0.02 g]. 
Morphometry.  Injections of BHRP into the left BC successfully labeled ipsilateral SNB 
motoneurons in all animals in a manner consistent with previous studies (Kurz et al., 1986; 
Goldstein and Sengelaub, 1990; Goldstein and Sengelaub, 1994; Burke et al., 1997; Burke et al., 
1999).  SNB motoneurons displayed their characteristic multipolar morphologies, with dendritic 
arbors projecting ventrolaterally, dorsomedially, and across the midline into the area of the 
contralateral SNB (Fig. 2.3).  The number of BHRP-labeled SNB motoneurons (51.30 ± 4.64) did 
not differ across groups [F(3,19) = 2.39, n.s.] 
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Figure 2.3.  (Left) Darkfield digital micrographs of transverse sections through the lumbar spinal 
cord of an intact male (top), an untreated castrate (second from top), a castrate treated with an 
estradiol implant from P7-P21 (E7-21; second from bottom), and a castrate treated with estradiol 
from P7-P28 (E 7-28; bottom) after BHRP injection into the left BC muscle at P28.  (Right) 
Computer-generated composites of BHRP-labeled somata and processes drawn at 320 µm 
intervals through the entire rostrocaudal extent of the SNB; these composites were selected as 
they are representative of their respective group average dendritic lengths.  Scale bar = 250 µm. 
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Soma Area.  The size of SNB somata at P28 differed significantly across groups [F(3,19) = 6.63, 
p < 0.05; Fig. 2.4].  The mean cross-sectional area of SNB somata in intact control males (837.77 
± 12.55 µm
2
) was typical.  The somata of untreated castrates (661.15 ± 21.11 µm
2
, reduced 
21%), or castrates treated with estradiol implants from P7-P21 (756.31 ± 101.4 µm
2
, reduced 
17%) or P7-P28 (647.26 ± 41.89 µm
2
, reduced 23%) were all significantly smaller than those of 
intact control males (LSDs, p < 0.05). 
Dendritic Length.  The overall length of SNB dendrites significantly differed across groups 
[F(3,19) = 17.02, p < 0.05; Fig. 2.5].  SNB dendritic length in intact control males was typical 
(5963.02 ± 473.75 µm), reflecting the exuberant growth that occurs over the first four postnatal 
weeks.  Dendritic lengths in castrates were approximately 67% shorter (1943.61 ± 604.17 µm) 
than those of intact control males at P28 (LSD, p < 0.05).  Treatment of castrates with estradiol 
implants from P7-P21 or P7-P28 resulted in dendritic lengths (8237.88 ± 1146.67 µm, 8198.10 ± 
417.01 µm, respectively) that were not different from those of intact control P28 males (LSDs, 
n.s.). 
Dendritic Distribution.  The SNB dendritic arbor of intact control males is radially organized but 
not uniformly distributed, with over 50% of the arbor concentrated ventrolaterally between 180 
and 300° (Goldstein et al., 1993).  The distribution of SNB dendrites showed an effect of group 
[repeated measures F(3,209) = 17.39, p < 0.05], as well as the typical significant effect of location 
[repeated measures F(11,209) = 80.48, p < 0.05; Fig. 2.6], and a group by location interaction 
[F(33,209) = 6.971, p < 0.05].  Castration not only reduced overall dendritic length, but it did so 
throughout the arbor, resulting in amounts of dendritic material per bin ranging from 26 to 42% of 
intact control male values [F(3,19) = 17.02, p < 0.05].  Castrates treated with estradiol implants 
from P7-P21 displayed a dendritic distribution that differed from that of intact control males [group 
by location interaction, F(11,99) = 44.80, p < 0.05].  This interaction was the result of an altered 
dendritic distribution in P7-P21 estradiol-treated castrates ventrolaterally between 210 and 240 
degrees, where the amount of dendritic arbor was increased by 155% [F(1,9) = 5.78, p < 0.05].  
Similarly, treating castrates with estradiol implants from P7-P28 resulted in an altered dendritic 
distribution, [group by location interaction, F(11,88) = 2.60, p < 0.05].  Again, this interaction was 
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Figure 2.4.  Soma areas of SNB motoneurons at P28 for intact males, untreated castrates 
(castrate), and castrates with estradiol implants from P7-P21 (E7-21) or from P7-P28 (E7-28).  Bar 
heights represent means ± SEM for four to six animals per group.  Asterisk denotes significantly 
different from intact control males.  
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Figure 2.5.  Dendritic lengths expressed as length of arbor per labeled SNB motoneuron at P28 
for intact males, untreated castrates (castrate), and castrates with estradiol implants from P7-P21 
(E7-21) or from P7-P28 (E7-28).  Bar heights represent means ± SEM for four to six animals per 
group.  Asterisk denotes significantly different from intact control males.  
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Figure 2.6.  (Top) Schematic drawing of spinal gray matter divided into radial sectors for measure 
of SNB dendritic distribution.  (Bottom) Length per radial bin of SNB dendrites at P28 for intact 
males, untreated castrates (castrate), and castrates with estradiol implants from P7-P21 (E7-21) or 
from P7-P28 (E7-28).  For graphical purposes, dendritic length measures have been collapsed into 
six bins of 60° each.  Bar heights represent means ± SEM for four to six animals per group.  
Asterisk denotes significantly different from intact control males.  
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the result of an altered dendritic distribution in P7-P28 estradiol-treated castrates ventrolaterally 
between 210-240 degrees [F(1,8) = 10.78, p < 0.05], where the amount of dendritic arbor was 
enhanced by 173%. 
Dendritic Extent.  The distance spanned by SNB dendrites in the rostrocaudal axis did not differ 
across treatment groups [F(3,19) = 1.22, n.s.; intact control males = 2432.00 ± 283.52 µm, 
castrates = 2377.14 ± 161.62 µm, castrates treated with estradiol from P7-P21 = 2693.33 ± 96.15 
µm, castrates treated with estradiol from P7-P28 = 2752.00 ± 93.30 µm]. The radial extent of 
BHRP labeling showed an effect of group [F(3,19) = 17.02, p < 0.05; Fig. 2.7].  The effect of 
group was due to decreases in radial extent in castrates; radial extent did not differ between 
intact control males and estradiol-treated castrates [F(2,13) = 0.17, n.s.]. 
 
DISCUSSION 
Immunolabeling for ERα in the BC muscle revealed the presence of ERα during 
development as well as in adulthood.  The percentage of ERα-positive muscle fibers in the BC 
muscle did not change with age.  In contrast, the density of ERα-positive extra-muscle fiber cells 
changed dramatically and was greatest during the early postnatal period, when estrogens act at 
the musculature to facilitate SNB dendritic growth, but absent in adulthood, when SNB 
motoneurons are insensitive to estrogens.  The current results suggest that ERα located within 
these extra-muscle fiber cells could be the site of action for estrogenic support of SNB 
motoneuron dendrite growth during the first four weeks of postnatal development in male rats. 
ERα Immunolabeling 
Binding of estrogens by the BC/LA muscle has been previously reported (Dube et al., 
1976), so the presence of ERs in this muscle was expected.  However, our results describe a 
specific isoform of the receptor—ERα—and its expression in this tissue, and further demonstrate 
that the BC’s ability to bind estrogens is present both throughout development and in adulthood.  
Interestingly, ERα immunostaining did not appear to be restricted to the nuclei of muscle fibers.  
This is consistent with previous reports of the localization of ERα in skeletal muscle, indicating the  
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Figure 2.7.  (Top) Schematic drawing of spinal gray matter divided into radial sectors for measure 
of SNB radial extent.  (Bottom) Radial extents of SNB dendrites at P28 for intact males, untreated 
castrates (castrate), and castrates with estradiol implants from P7-P21 (E7-21) or from P7-P28 (E7-
28).  For graphical purposes, dendritic extent measures have been collapsed into six bins of 60° 
each.  Bar heights represent means ± SEM for four to six animals per group. 
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presence of ERα in cytosol, and in association with particular subcellular fractions (e.g., 
mitochondrial; Milanesi et al., 2008). 
Our results demonstrate that the percentage of ERα-positive muscle fibers did not differ 
across development or in adulthood.  Because BC muscle fiber number is stable across the time 
points used in this study (Tobin and Joubert, 1991), measurements of ERα-positive muscle fibers 
are not biased by an alteration in total muscle fiber number.  Furthermore, since there is a change 
in estrogen’s effects on dendrites from development to adulthood, but the proportions of ERα-
positive muscle fibers do not change during these time periods, it is unlikely that ERα expression 
within muscle fibers mediates these transient estrogenic effects on SNB dendrites.  It is possible 
that the other predominant ER isoform—ERβ—could mediate the estrogenic effects on SNB 
dendrites via the BC.  Therefore, not observing a change in ERα expression in muscle fibers 
does not rule out a role of muscle fibers in the estrogenic support of motoneuron dendrite growth 
during the early postnatal period.  However, it is also possible that ERβ is not expressed in BC 
muscle, because there is great variability in the differential expression of ERα and ERβ 
depending on the target tissue and many other factors (Banie et al., 2008). 
Although ERα expression in muscle fibers did not change across ages, the density of 
ERα-positive extra-muscle fiber cells was significantly different during early postnatal 
development compared to adult animals.  We found that the density of ERα-positive extra-muscle 
fiber cells was significantly higher in P7 and P14 animals compared to adults.  These results 
demonstrate that ERα is present in BC extra-muscle fiber cells during the time when estrogens 
act at this muscle to promote SNB dendritic growth.  The density of ERα-positive extra-muscle 
fiber cells is substantially lower or zero at later ages, when SNB motoneurons are insensitive to 
estrogens.  Since the expression of ERα in extra-muscle fiber cells coincides with the critical 
period for estrogen action at the muscle on SNB dendritic growth, this suggests that these cells 
could be the site of action for estrogen-mediated SNB dendritic growth during the early postnatal 
period. 
Previous work has demonstrated that the robust growth of SNB dendrites during the first 
four postnatal weeks of life is steroid-dependent (Goldstein et al., 1990).  These studies all used 
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treatment periods lasting through P28.  Based on the changes in density of ERα-positive BC 
extra-muscle fiber cells we hypothesized that the critical period for estradiol exposure in 
supporting dendritic growth ended earlier than P28.  Our results demonstrate that the period of 
high density of ERα-positive BC extra-muscle fiber cells may define the critical period for 
estrogen-dependent SNB dendrite growth during the early postnatal period: treating castrates 
with estradiol implants at the BC muscle when the density of ERα-positive extra-muscle fiber cells 
is high fully supports SNB dendrite growth, resulting in dendrite lengths that are not different from 
those of P28 intact control males or animals treated from P7-P28 with estradiol implants at the 
BC. 
Target Musculature 
BC/LA muscle development is androgen-dependent (Čihák et al., 1970; Tobin and 
Joubert, 1991).  In males, the number of myotubes, mononucleate cells, and muscle fibers in the 
BC/LA increases during the first week of life, and exposure to androgens during the first week of 
life is sufficient to support BC/LA growth through P28 (Hebbeler and Sengelaub, 2003; Tobin and 
Joubert, 1991; present study).  Furthermore, because BC/LA weights did not differ, any difference 
in SNB morphology could not be due to differences in muscle size. 
Motoneuron Morphology 
Somata.  In normal males most SNB somal growth occurs during the first four postnatal weeks, 
and this increase in soma size is androgen-dependent (Breedlove and Arnold, 1983; Breedlove 
and Arnold, 1983; Goldstein and Sengelaub, 1990; Goldstein and Sengelaub, 1994).  In the 
present study, SNB somata in castrates were smaller than those of intact control males, 
consistent with previous findings demonstrating the androgen-dependence of SNB soma growth.  
Treatment of castrates with estradiol (from P7-P21 or P7-P28) did not support SNB somal growth 
during the first four postnatal weeks, consistent with previous work demonstrating that estradiol 
fails to masculinize SNB soma size (Breedlove et al., 1982; Goldstein and Sengelaub, 1994; 
Burke et al., 1997; Hebbeler et al., 2002; Nowacek and Sengelaub, 2006) and blocking synthesis 
of estrogens with aromatase inhibition does not interfere with the development of masculine soma 
size (Burke et al., 1999). 
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Dendrites.  Our results demonstrate that castration results in significantly reduced SNB dendrite 
lengths, replicating previous findings (Goldstein et al., 1990; Goldstein and Sengelaub, 1994; 
Nowacek and Sengelaub, 2006).  Furthermore, these results confirm the neuromuscular 
periphery as the site of action for estrogen-dependent SNB dendrite growth during the early 
postnatal period (Nowacek and Sengelaub, 2006).  ERs are found in non-muscle fiber cells, 
including terminal Schwann cells (Jung-Testas et al., 1993).  In the current study, we 
demonstrated that ERα expression in a BC extra-muscle fiber cell type coincides with the early 
postnatal period during which estradiol acts at the target musculature to promote SNB dendrite 
growth.  Together, these data suggested that ERα expression in the BC muscle could be the site 
of action for mediating the critical period for estrogen-dependent SNB dendrite growth during the 
early postnatal period.  In the present study, we restricted estradiol treatment at the BC muscle to 
the period when the density of ERα-positive extra-muscle fiber cells was highest (P7-P21).  Our 
results support the hypothesis that the period of estrogen-dependent SNB dendrite growth is 
potentially defined by the presence of ERα in extra-muscle fiber cells in the BC, as animals 
treated with estradiol implants from P7-P21 had dendritic arbors that were not different than intact 
control animals or castrates treated with estradiol implants from P7-P28. 
Previous work has demonstrated the importance of the target musculature in the 
regulation of estradiol-dependent SNB dendrite growth.  Whereas estrogens are important during 
early postnatal development for SNB dendritic growth, SNB motoneurons do not accumulate 
estradiol during development (Taylor et al., 1995) or in adulthood (Breedlove and Arnold, 1980; 
Breedlove and Arnold, 1983), suggesting that these hormones exert their effect of SNB dendritic 
growth indirectly.  Neither primary sensory nor supraspinal afferents appear to be involved in SNB 
dendritic growth (Goldstein et al., 1996; Hays et al., 1996; Hebbeler and Sengelaub, 2003), and it 
has been suggested that the growth and differentiation of dendrites may be initiated and shaped 
by contact with the target tissues (Sumner and Watson, 1971; Yawo, 1987; Voyvodic, 1989).  
Furthermore, blocking androgen receptors at the BC muscle in adulthood results in a reduction of 
SNB dendritic lengths, demonstrating that hormone receptors in target tissues are critical for the 
target-mediated hormonal regulation of SNB morphology (Rand and Breedlove, 1995).  Our data 
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provide further evidence that estradiol-dependent SNB dendrite growth is regulated at the target 
musculature, and indicate that hormone receptor expression in BC muscles mediates this target-
dependent dendrogenesis. 
Similarly, our results indicate that hormone receptor expression in the target musculature 
can regulate motoneuron dendrite morphology.  Recent work has demonstrated that there is a 
causal relationship between androgen receptor expression in the target musculature and degree 
of androgen sensitivity exhibited by the innervating motoneurons (Huguenard et al., 2011).  By 
manipulating the expression of androgen receptors exclusively in the target musculature, 
androgen sensitivity was induced in a population of normally androgen-insensitive motoneuron 
dendrites, demonstrating that androgen sensitivity is directly conferred by receptor expression in 
the target musculature (Huguenard et al., 2011).  Along with our findings, these results further 
implicate the importance of receptor expression in the target muscles for hormonal regulation of 
motoneuron morphology. 
When examining the differences in dendritic distribution across groups, we found that 
treatment of castrates with estradiol at the BC muscle (either from P7-P21 or P7-P28) resulted in 
significantly longer SNB dendrites in the gray matter ventrolateral to the central canal compared 
to intact control animals.  This area of SNB dendritic arbor where estrogen treatment promotes 
enhanced dendritic growth compared to intact control males has previously been identified as an 
important source of excitatory drive to the SNB (Tanaka and Arnold, 1993), and shows specific 
reductions in dendritic length following spinal transection early in development (Hebbeler and 
Sengelaub, 2003).  Future research should determine why estradiol treatment at the BC muscle 
in castrates drives SNB dendritic development in this area of the arbor that is specialized for 
receiving excitatory inputs. 
Comparability of BHRP labeling 
Previous studies have demonstrated that neither axonal transport of BHRP (Leslie et al., 
1991) nor dendritic transport as demonstrated by the rostrocaudal or mediolateral extent of 
dendritic labeling (Kurz et al., 1990; Goldstein and Sengelaub, 1994) is affected by hormone 
levels.  In the present study, the possibility that hormone manipulations could affect retrograde 
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transport is an important consideration, as such artifact could potentially result in apparent 
alterations in dendritic morphology.  No difference in rostrocaudal extents of SNB dendrites were 
observed, but radial extents in untreated castrates were smaller than those of intact control 
males.  This result most likely reflects the attenuated growth of SNB dendrites rather than a 
transport artifact, which (because rostrocaudal extent was not affected) would necessarily have 
had to occur selectively in the transverse plane.  In contrast, no differences in either rostrocaudal 
or radial extents of dendrites were observed between intact control males and estradiol-treated 
castrates, indicating that the ability of SNB dendrites to transport BHRP out to the most distal, 
highest order branches was not affected in these groups.  Thus, we believe the dendritic labeling 
across groups was comparable, allowing direct comparisons of dendritic length and distribution 
across groups. 
Mechanisms of target-mediated dendritic growth 
Specific features of the SNB system, including perineal muscle development and 
motoneuron morphology, are regulated by testosterone action at androgen receptors during a 
perinatal critical period (Freeman et al., 1996).  To test the hypothesis that androgen receptors in 
BC/LA muscle fibers are directly responsible for testosterone-mediated masculinization of the 
SNB system, Niel et al. (2009) created a transgenic animal that expressed androgen receptors 
only in muscle fibers, but not other cell types.  Despite the expression of androgen receptors, 
SNB motoneurons and the LA muscle exhibited the female phenotype in these animals, 
demonstrating that androgen receptor expression within muscle fibers was not sufficient to 
mediate sexual differentiation in this system.  These authors suggested, as we do, that it is the 
expression of hormone receptors in a non-muscle fiber cell type in the BC/LA that is responsible 
for hormone effects on the SNB neuromuscular system (Niel et al., 2009). 
These extra-muscle fiber cells could be fibroblasts, adipocytes, endothelial cells, 
epithelial cells, or Schwann cells, and it could be a change in ER in these cells or a change in the 
amount of these cells themselves, that mediates the change in SNB estrogen sensitivity from the 
early postnatal period to adulthood.  While it is unclear how estradiol action at extra-muscle fiber 
ERα promotes SNB dendrite growth, a possible mechanism of action could be through the 
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regulation of growth factors.  For example, in adulthood, androgens regulate brain-derived 
neurotrophic factor (BDNF) expression in the target musculature, and BDNF can reduce SNB 
dendritic length (Verhovshek et al., 2010a; Verhovshek and Sengelaub, 2010).  Similarly, the 
ERα-positive extra-muscle fiber cells present postnatally could be supporting dendritic growth by 
suppressing BDNF expression during the early postnatal period.  Future studies are needed to 
determine the identity of the extra-muscle fiber cells and their role during development (see 
Chapter 5). 
In conclusion, the current data suggest that changes in ERα expression in the BC could 
define the critical period in which estrogens act at the target musculature to regulate SNB 
dendritic growth during the early postnatal period.  Why this expression in extra-muscle fiber cells 
is limited to the postnatal period, and the mechanism by which it supports SNB dendrite growth 
remains to be determined. 
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CHAPTER 3:  Rudolph, L.M. & Sengelaub, D.R. (2013). Castration-induced upregulation of 
muscle ERα supports estrogen sensitivity of motoneuron dendrites in a sexually 
dimorphic neuromuscular system.  Developmental Neurobiology. 73(12): 921-935. 
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BACKGROUND 
In Chapter 2, I demonstrated that ERα expression in BC extra-muscle fiber cells 
coincides with the period for estrogen-dependent dendrite growth in the SNB, and potentially 
mediates the estrogen sensitivity of SNB morphology (Rudolph and Sengelaub, 2013a).  ERα 
expression in extra-muscle fiber cells of the SNB target muscle could regulate the estrogen 
sensitivity of SNB dendrites: extra-muscle fiber ERα is high during the first few weeks of life, 
declining through P21, and is reduced or absent in adulthood, when SNB dendrites are 
unresponsive to estrogens.  Treatment of castrated males with estradiol restricted to the period of 
elevated ERα expression in BC extra-muscle fiber cells (P7-P21) results in full masculinization of 
SNB dendritic morphology at P28 (Rudolph and Sengelaub, 2013a).  Therefore, it appears that 
ERα expression in extra-muscle fiber cells is critical for estrogen-regulated masculinization of 
SNB motoneuron morphology during development.  Similarly, the masculinization of SNB 
motoneuron number is thought to be mediated by hormone action at non-muscle fiber cells in the 
target musculature (Niel et al., 2009).  These data indicate a clear role for gonadal hormone 
receptor expression in extra-muscle fiber cells of the SNB target musculature in the 
developmental masculinization of SNB motoneurons. 
The developmental expression patterns of ERα in BC muscle coincide with the transient 
period of estrogen sensitivity of SNB dendrites (Rudolph and Sengelaub, 2013a).  However, it is 
unclear why levels of ERα in extra-muscle fiber cells decrease during the postnatal period.  It is 
possible that ERα in BC extra-muscle fiber cells is downregulated by gonadal hormones.  In 
female rat dorsal root ganglia, ER mRNA levels are low during proestrus (when circulating 
estrogens are elevated; Sohrabji et al., 1994).  Levels of ER mRNA are high after removal of 
estrogens by ovariectomy, and estrogen treatment of ovariectomized animals reduces ER mRNA 
to levels of those found in proestrus animals (Sohrabji et al., 1994).  Similarly, ovariectomy-
induced increases in ERα mRNA and protein occur in skeletal muscles of female mice (Baltgavis 
et al., 2010).  ERα mRNA in soleus and extensor digitorum longus muscles and ERα protein in 
tibialis anterior muscle increase significantly after castration, and either acute (48 hour) or chronic 
(21 day) estradiol treatment in castrates returns muscle ERα levels to those of intact animals 
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(Baltgavis et al., 2010).  Together, these data suggest that developmental downregulation of 
extra-muscle fiber cell ERα in the SNB target muscle is potentially caused by the presence of 
gonadal hormones.  We hypothesized that castration would result in an attenuation of the 
developmental decrease in ERα in the SNB target musculature.  In Experiment 1, we castrated 
male rats on P7 and measured ERα immunolabeling in the BC muscle at P21 and compared this 
immunolabeling to that of gonadally intact P21 males. 
 
Experiment 1 
MATERIALS AND METHODS 
Animals.  Untimed pregnant rat dams (Sprague-Dawley, Harlan, Indianapolis, IN) were 
maintained on a 12-h light, 12-h dark cycle, with unlimited access to food and water.  When 
pregnant females gave birth (day of birth = P1), pups were sexed and litters were culled to eight 
pups when necessary, retaining males preferentially.  One group of males remained gonadally 
intact (n = 6) and another group was bilaterally castrated under isoflurane anesthesia at P7 (n = 
6).  All procedures were carried out in accordance with the NIH Guide for the Care and Use of 
Laboratory Animals and approved by the Bloomington Institutional Animal Care and Use 
Committee. 
Immunohistochemistry.    At P21 animals were weighed, given an overdose of urethane (0.5 
ml/100 g of body weight), and perfused transcardially with 0.9% saline followed by cold 4% 
paraformaldehyde in 0.1M phosphate buffer (pH = 7.4).  The BC/LA muscles were removed and 
postfixed in the same fixative for 24 h and transferred to 30% sucrose in 0.1M phosphate buffer 
for a minimum of 24 h of cryoprotection.  The BC/LA was cut horizontally into 12 μm sections on 
a cryostat at -16°C.  Sections were thaw-mounted onto gelatin-coated slides, and stored at -16°C.  
Immunohistochemistry proceeded according to previously used methods (Rudolph and 
Sengelaub, 2013a; Chapter 2). 
Microscopic Analysis.  Because all of our previous developmental work on SNB motoneuron 
dendritic growth, hormone sensitivity, critical period effects, and the characterization of 
developmental changes in ERα was done in BC-projecting motoneurons, the current analysis 
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was limited to the BC muscle, as it was in Chapter 2.  Sections were first viewed under 
epifluorescent illumination to visualize basal lamina staining.  The BC is a relatively complex 
muscle, with muscle fibers traveling in several different directions, resulting in fields containing 
both cross- and longitudinally-sectioned muscle fibers (Fargo et al., 2003); fields containing large 
numbers of basal lamina-stained muscle fibers in cross-section were selected for analysis.  Using 
Stereo Investigator (MBF Bioscience, Inc., Williston, VT), muscle fibers were sampled 
systematically at 2200X (final magnification on display), by superimposing a grid on the tissue 
image (e.g., 75 µm x 75 µm square frame) and sampling all fibers within the frame; only fields 
containing a minimum of 23 muscle fibers were examined. 
To quantify ERα immunostaining, muscle fibers were visualized under FITC fluorescence 
and images were captured for subsequent analysis.  Areas that appeared to be labeled relative to 
background (see below) were identified as either in-fiber or extra-fiber depending on the location 
of ERα label relative to the basal lamina stain.  One field per section and 1-2 sections per animal 
were analyzed; overall, an average 76.5 muscle fibers per animal were traced.  For each 
analyzed tissue section, the mean and standard deviation of muscle fiber FITC luminance values 
were calculated and a minimum labeling criterion of the mean plus two standard deviations was 
established for each section.  Cells that exceeded this criterion were identified as ERα-positive 
and were categorized as either ERα-positive muscle fibers (if surrounded by a basal lamina) or 
ERα-positive extra-muscle fiber cells.  We sampled equivalent numbers of muscle fibers across 
groups and expressed ERα-positive muscle fibers as a percentage of the sample.  ERα-positive 
extra-muscle fiber cells were identified only on the basis of ERα labeling, and their numbers were 
expressed as a density per unit area or as a ratio relative to the number of muscle fibers 
sampled.  The percentage of ERα-positive muscle fibers and density of ERα-positive extra-
muscle fiber cells per section were analyzed using one-way ANOVAs with Fisher’s LSD post-hoc 
tests.  Differences were considered significant if p < 0.05. 
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RESULTS 
As reported previously (Rudolph and Sengelaub, 2013a), ERα immunolabeling was 
present in both muscle fibers (label contained within the basal lamina stain) and extra-muscle 
fiber cells (label outside basal lamina stain; Fig. 3.1).  The average number of muscle fibers 
analyzed per animal did not differ between groups [F(1,10) = 0.25, n.s.].  For each animal, the 
number of labeled muscle fibers was expressed as a percentage of total muscle fibers sampled.  
The percentage of ERα-positive muscle fibers did not differ between normal (3.15 ± 1.12%) and 
castrated males [2.65 ± 1.02%; F(1,10) = 0.11, n.s.; Fig. 3.2]. 
There was a significant main effect of castration on the density of ERα-positive extra-
muscle fiber cells.  ERα expression in extra-muscle fiber cells was significantly greater in 
castrated animals (740.74 ± 148.15 per mm
2
) compared to that of normal animals (109.26 ± 
46.83 per mm
2
); [F(1,10) = 16.52, p < 0.05; Fig. 3.2].  Similarly, the number of ERα-positive extra-
muscle fiber cells relative to the number of muscle fibers sampled was significantly increased in 
castrated animals (8.67 ± 1.25 per 100 muscle fibers) compared to that of normal animals (1.47 ± 
0.60 per 100 muscle fibers); [F(1,10) = 27.17, p < 0.01; Fig. 3.2].  Changes in androgens during 
the postnatal period examined in this experiment have no effect on muscle weight (Hebbeler and 
Sengelaub, 2003; Experiment 2, current chapter) or fiber number in the SNB target musculature 
(Tobin and Joubert, 1991).  Thus the increase in ERα-positive extra-muscle fiber cells as a 
function of area or relative to the number of muscle fibers sampled is not likely a result of 
changes in BC/LA size or fiber number. 
 
Experiment 2 
In Experiment 1, we found that the density of ERα-positive BC extra-muscle fiber cells at 
P21 was significantly greater in animals castrated at P7 compared with normal males.  Based on 
these results, and earlier data demonstrating that extra-muscle fiber ERα expression coincides 
with the critical period for estrogen-dependent SNB dendrite growth, we hypothesized that the 
elevated ERα expression in BC extra-muscle fiber cells in castrated animals would result in 
heightened estrogen sensitivity of SNB dendrites.  To test this hypothesis, in Experiment 2 we  
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Figure 3.1.  Digital light micrographs of cross-sections of BC muscle in normal (A, B) and 
castrated (C, D) male rats at P21; higher magnification views (B, D) of indicated areas.  Each row 
shows the same tissue section viewed under different epifluorescent illumination, demonstrating 
immunolabeling for basal lamina only (red; left), ERα only (green; middle), and the merged image 
-positive 
extra-muscle fiber cells; note the absence of basal lamina staining of the indicated extra-muscle 
fiber cells in rows B, D.  Scale bars = 25 µm.  
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Figure 3.2.  The percentage of ERα-positive muscle fibers (left), density of ERα-positive extra-
muscle fiber cells (middle), and ratio of ERα-positive extra-muscle fiber cells to muscle fibers in 
the BC muscle at P21 in normal males and males castrated at P7.  Bar heights represent means 
± SEM for six animals per group.  * denotes significantly different from normal males.
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assessed SNB dendritic morphology at P28 in normal males, untreated castrates, castrates 
treated with estradiol implants from P21 to P28, and normal males treated with estradiol implants 
from P21 to P28. 
 
MATERIALS AND METHODS 
Animals. Untimed pregnant rat dams (Sprague-Dawley; Harlan, Indianapolis, IN) were 
maintained on a 12-h light, 12-h dark cycle, with unlimited access to food and water. Litters were 
culled to eight pups when necessary, retaining males preferentially.  Males were bilaterally 
castrated under isoflurane anesthesia at P7.  One group of castrates had estradiol implants 
placed at the left BC muscle at P21, remaining until P28 (n = 7); another group of castrates 
remained untreated (n = 7).  Age-matched normal males were also included, one group was left 
untreated (n = 5) and another group received estradiol implants at the left BC muscle from P21 to 
P28 (n = 5; overall n = 24).  All procedures were carried out in accordance with the NIH Guide for 
the Care and Use of Laboratory Animals and approved by the Bloomington Institutional Animal 
Care and Use Committee. 
Implants.  To restrict hormone treatment to the SNB target musculature, we used our previous 
method (Nowacek and Sengelaub, 2006; Rudolph and Sengelaub, 2013a; Chapter 2) to deliver 
estradiol locally to the BC muscle. 
Histochemistry.  Horseradish peroxidase conjugated to the cholera toxin β subunit (BHRP; List 
Biological, Campbell, CA) was used to retrogradely label SNB motoneurons innervating the BC 
muscle, as previously described (Chapter 2). 
Motoneuron Somata.  The number of BHRP-filled motoneurons was assessed in all sections 
through the entire rostrocaudal extent of the SNB for all animals, as previously described 
(Chapter 2).  The cross-sectional soma area of BHRP-labeled motoneurons was measured in an 
average of 22.63 motoneurons for each animal. 
Dendritic Length.  For each animal, dendritic lengths in a single representative set of alternate 
sections were measured under darkfield illumination.  Potential redistributions of dendrites as well 
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as the comparability of BHRP labeling across treatment groups were assessed using previously 
described methods (Rudolph and Sengelaub, 2013a; Chapter 2). 
 
RESULTS 
BC/LA Muscle Weight.  Body weights differed across groups [F(3,17) = 3.89, p < 0.05], being 
largest in normal males and castrated males (LSD, n.s.) and smaller in estradiol-treated animals 
(LSD, n.s.; Table 3.1).  BC/LA muscle weight showed an identical pattern of differences [F(3,17) 
= 19.47, p < 0.01; Table 3.1].  Differences in muscle weight remained after correcting for 
differences in body weight [raw muscle weight / body weight) x 100]: BC/LA muscle weights 
showed a significant effect of group [F(3,17) = 22.94, p < 0.01; normal males = 0.100 ± 0.002 g, 
castrates = 0.094 ± 0.004 g, castrates treated with estradiol implants from P21-P28 = 0.072 ± 
0.002 g, normal males treated with estradiol from P21-P28 = 0.077 ± 0.004 g].  The corrected 
weights of BC/LA muscles from animals treated with estradiol implants were significantly lower 
than those of normal and castrated males (LSDs, p < 0.01). 
Morphometry.  Injections of BHRP into the left BC successfully labeled ipsilateral SNB 
motoneurons in all animals in a manner consistent with previous studies (Kurz et al., 1986; 
Goldstein and Sengelaub, 1990; Goldstein and Sengelaub, 1994; Burke et al., 1997; Burke et al., 
1999).  SNB motoneurons displayed their characteristic multipolar morphologies, with dendritic 
arbors projecting ventrolaterally, dorsomedially, and across the midline into the area of the 
contralateral SNB (Fig. 3.3).  The number of BHRP-labeled SNB motoneurons (61.17 ± 5.59) did 
not differ across groups [F(3,20) = 0.02, n.s.; Table 3.1]. 
Soma Area.  The size of SNB somata at P28 differed significantly across groups [F(3,20) = 3.90, 
p < 0.05; Fig. 3.4].  The mean cross-sectional area of SNB somata in normal males (749.30 ± 
23.78 µm
2
) was typical.  The somata of untreated castrates (661.15 ± 21.11 µm
2
, reduced 12%), 
or castrates treated with estradiol implants from P21-P28 (638.18 ± 13.77 µm
2
, reduced 15%) 
were both significantly smaller than those of normal males (LSDs, p < 0.05).  The areas of SNB 
somata of normal males treated with estradiol from P21-P28 (702.92 ± 40.43 µm
2
) were not 
different than those of untreated normal males (LSD; n.s.). 
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Table 3.1.  Raw body and muscle weights and number of BHRP-labeled motoneurons (Means ± 
SEM) in normal males, castrated males, castrated males treated with estradiol from P21-P28, 
and normal males treated with estradiol from P21-P28 
 Normal Castrate Castrate + E21-28 Normal +E21-28 
Body weight (g) 89.40 ± 5.86 
100.25 ± 
4.73 
85.57 ± 2.07
† 
79.40 ± 4.18
† 
BC/LA weight (g) 
0.091 ± 
0.007 
0.094 ± 
0.005 
0.061 ± 0.001
*† 
0.060 ± 0.002
*†
 
BHRP-labeled 
motoneurons 
60.00 ± 
11.38 
63.43 ± 7.58 60.57 ± 10.16 60.00 ± 19.8 
 
*
Significantly different from normal males 
†
Significantly different from castrated males  
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Figure 3.3.  (Left) Darkfield digital micrographs of transverse sections through the lumbar spinal 
cord of a normal male (top), an untreated castrate (second from top), a castrate treated with an 
estradiol implant from P21-P28 (Castrate + E21-28; second from bottom), and a normal male 
treated with an estradiol implant from P21-P28 (Normal + E21-28; bottom) after BHRP injection into 
the left BC muscle at P28.  (Right) Computer-generated composites of BHRP-labeled somata and 
processes drawn at 320 µm intervals through the entire rostrocaudal extent of the SNB; these 
composites were selected as they are representative of their respective group average dendritic 
lengths.  Scale bar = 250 µm.  
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Figure 3.4.  Soma areas of SNB motoneurons at P28 for normal males, untreated castrates 
(castrate), castrates treated with estradiol implants from P21-P28 (castrate + E21-28), and normal 
males treated with estradiol implants from P21-P28 (normal + E21-28).  Bar heights represent 
means ± SEM for four to seven animals per group.  * denotes significantly different from normal 
males.
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Dendritic Length.  The overall length of SNB dendrites significantly differed across groups [F(3, 
20) = 14.97, p < 0.01; Fig. 3.5].  SNB dendritic length in normal males was typical (5963.02 ± 
473.75 µm), reflecting the exuberant growth that occurs over the first four postnatal weeks.  
Dendritic lengths in castrates were approximately 67% shorter (1943.61 ± 604.17 µm) than those 
of normal males (LSD, p < 0.05).  Castrates treated with estradiol from P21-P28 had SNB 
dendritic arbors (8978.28 ± 1150.46 µm) that were significantly greater than those of normal 
males and untreated castrates (LSD, p < 0.05).  Dendritic lengths of normal males treated with 
estradiol from P21-P28 (4708.33 ± 420.29 µm) were no different from those of untreated normal 
males (LSD, n.s.). 
Dendritic Distribution.  The SNB dendritic arbor of normal males is radially organized but not 
uniformly distributed, with over 50% of the arbor concentrated ventrolaterally between 180 and 
300° (Goldstein et al., 1993).  The distribution of SNB dendrites showed an effect of group 
[repeated measures F(3,209) = 13.03, p < 0.01], as well as the typical significant effect of location 
[repeated measures F(11,209) = 42.04, p < 0.01; Fig. 6], and a group by location interaction 
[F(33,209) = 3.12, p < 0.01].  Castration not only reduced overall dendritic length, but it did so 
throughout the arbor, resulting in amounts of dendritic material per bin ranging from 26 to 42% of 
normal male values [F(1,10) = 23.31, p < 0.05].  Treatment of castrates with estradiol from P21-
P28 not only prevented reductions in dendrite lengths [F(1,11) = 35.40, p < 0.05], but resulted in 
dendritic hypertrophy throughout the arbor [F(1,9) = 8.30, p < 0.05], with dendritic arbors of P21-
P28 estradiol-treated castrates ranging from 152-234% of those of normal males.  In normal 
males, SNB dendritic distribution was not affected by estradiol treatment from P21-P28 [F(1,8) = 
0.04, n.s.]. 
Dendritic Extent.  The distance spanned by SNB dendrites in the rostrocaudal axis showed a 
difference across groups [F(3,20) = 3.61, p < 0.05; normal males = 2720.00 ± 208.61 µm, 
castrates = 2377.14 ± 161.62 µm, castrated treated with estradiol from P21-P28 = 2971.43 ± 
109.62 µm, normal males treated with estradiol from P21-P28 = 2976.00 ± 148.38 µm].  This 
effect of group was due to decreases in rostrocaudal extent of dendrites in castrates; rostrocaudal 
extent did not differ between normal males and estradiol treated animals [F(2,14) = 0.87, n.s.].   
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Figure 3.5.  Dendritic lengths expressed as length of arbor per labeled SNB motoneuron at P28 
for normal males, untreated castrates (castrate), castrates treated with estradiol implants from 
P21-P28 (castrate + E21-28), and normal males treated with estradiol implants from P21-P28 
(normal + E21-28).  Bar heights represent means ± SEM for four to seven animals per group.  * 
denotes significantly different from normal males; † indicates significantly different from castrated 
males.  
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Figure 3.6.  (Inset) Schematic drawing of spinal gray matter divided into radial sectors for 
measure of SNB dendritic distribution.  Length per radial bin of SNB dendrites at P28 for normal 
males, untreated castrates (castrate), castrates treated with estradiol implants from P21-P28 
(castrate + E21-28), and normal males treated with estradiol from P21-P28 (normal + E21-28).  For 
graphical purposes, dendritic length measures have been collapsed into six bins of 60° each.  Bar 
heights represent means ± SEM for four to seven animals per group.  * denotes significantly 
different from normal males; † indicates significantly different from castrated males.
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The radial extent of BHRP labeling showed an effect of group [F(3,19) = 3.79, p < 0.05].  The 
effect of group was due to decreases in radial extent in castrates; radial extent did not differ 
between normal males and estradiol-treated animals [F(2,13) = 2.73, n.s.]. 
 
DISCUSSION 
Immunolabeling for ERα in the BC muscle at P21 in castrated and gonadally intact males 
revealed ERα expression in muscle fibers and extra-muscle fiber cells.  While the percentage of 
ERα-positive muscle fibers was unaltered by castration, the density of extra-muscle fiber cells 
immunolabeled for ERα was significantly greater in castrates compared with gonadally intact 
males.  The castration-induced increase in muscle ERα appears to have functional 
consequences for SNB morphology, as 7 days of estradiol treatment was sufficient not only to 
masculinize SNB dendrites at P28, but cause dendritic growth that exceeded that of normal 
males.  These data demonstrate that gonadal hormones regulate ERα expression in the SNB 
target musculature, and suggest that the density of ERα in BC extra-muscle fiber cells determines 
the estrogen sensitivity of SNB dendrites.  Furthermore, to our knowledge, this is the first 
demonstration that the timing of a sensitive period in sexual differentiation can be regulated by 
gonadal hormones. 
ERα Immunolabeling 
It has been known for some time that the BC/LA binds estrogens (Dube et al., 1976), and 
more recently that the BC muscle expresses ERα (Rudolph and Sengelaub, 2013a).  In our 
previous study describing the developmental expression of ERα in the BC muscle, we found that 
ERα immunolabeling in BC muscle fibers did not change across ages (Rudolph and Sengelaub, 
2013a).  The current results demonstrate that ERα expression in BC muscle fibers at P21 is 
unaltered by castration on P7.  This constancy in ERα expression in BC muscle fibers, regardless 
of age or hormone treatment, suggests that the temporally restricted effects of estrogen on SNB 
motoneuron morphology are not mediated by muscle fiber ERα. 
Our previous work showed that ERα expression in extra-muscle fiber cells is high during 
the early postnatal period, decreases around P21 and is absent in adulthood (Rudolph and 
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Sengelaub, 2013a).  The current study suggests a potential explanation for the downregulation of 
ERα-positive extra-muscle fiber cells in the BC, the presence of gonadal hormones.  Consistent 
with the present data, in dorsal root ganglia and skeletal muscles, ER mRNA and ERα mRNA 
and protein are upregulated after castration, and estradiol treatment in castrates decreases ER 
levels to those found in gonadally intact animals (Baltgavis et al., 2010; Sohrabji et al., 1994).  
Future studies should determine if treatment of castrates with estradiol (or androgenic gonadal 
hormones) prevents the castration-induced upregulation in extra-muscle fiber ERα. 
It is possible that other ER isoforms, including ERβ play a role in the estrogenic effects on 
SNB motoneuron dendrites.  In other skeletal muscles, however, ERα appears to be the 
predominant form of receptor.  Skeletal muscle ERα expression is 180 times greater than that of 
ERβ in humans (Wiik et al., 2003).  In mice, ERα expression is more abundant than ERβ 
(Baltgavis et al., 2010), and in some cases ERβ levels are undetectable (Couse et al., 1997).  
Furthermore, ERβ in mouse skeletal muscle was not affected by ovariectomy with or without 
estradiol replacement (Baltgavis et al., 2010). 
Target Musculature 
BC/LA muscle development requires androgens (Čihák et al., 1970; Tobin and Joubert, 
1991).  During the first postnatal days the number of myotubes, mononucleate cells, and muscle 
fibers show an androgen-dependent increase, and androgen exposure during this time is 
sufficient to maintain BC/LA development through P28 (Hebbeler and Sengelaub, 2003; Tobin 
and Joubert, 1991).  In the present study, BC/LA weights at P28 males castrated at P7 did not 
differ from those of normal males.  Aromatase inhibition in gonadally intact males also does not 
affect BC/LA muscle growth, demonstrating that androgen-dependent BC/LA development is not 
mediated by the conversion of testosterone to its estrogenic metabolites (Burke et al., 1999).  
While androgens promote BC/LA development, estradiol does not appear to have any trophic 
effects on the BC/LA (Jordan et al., 1995).  In fact, estrogen treatment in castrated males inhibits 
prepubertal increases in BC/LA weight (Hebbeler and Sengelaub, 2003), and BC/LA weight at 
P28 is decreased in castrated males given estradiol implants at the BC muscle compared to 
gonadally intact animals (Nowacek and Sengelaub, 2006).  In the present study, BC/LA weights 
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in normal animals treated with estradiol at the muscle from P21-P28 were also smaller than those 
of untreated normal males.  Based on these data, it appears that estradiol not only fails to support 
normal BC/LA growth, but can produce atrophic effects in gross muscle morphology.  
Interestingly, while estradiol induces muscle atrophy in gonadally intact males, their SNB dendritic 
lengths develop normally, and castrated males treated with estradiol at the muscle show SNB 
dendritic hypertrophy despite having reduced BC/LA weights.  This dissociation suggests that the 
estrogenic support of dendritic growth is not dependent on muscle size per se, but is potentially 
mediated by other cellular functions of muscle cells or other cell types in the neuromuscular 
periphery (Nowacek and Sengelaub, 2006). 
Motoneuron Morphology 
Somata 
In normal males, most SNB somal growth occurs during the first four postnatal weeks, 
and by P28 SNB somata are approximately 75% of their adult sizes (Goldstein et al., 1990).  
Similar to the BC/LA, SNB somal growth is androgen-dependent (Breedlove and Arnold, 1983a,b; 
Goldstein and Sengelaub, 1990; Goldstein and Sengelaub, 1994): blocking estrogen synthesis 
with aromatase inhibition does not alter normal SNB somal growth (Burke et al., 1999) and 
treating castrates with estradiol through injections or implants fails to masculinize SNB somata 
(Breedlove et al., 1982; Goldstein and Sengelaub, 1994; Hebbeler et al., 2002; Nowacek and 
Sengelaub, 2006; Rudolph and Sengelaub, 2013).  Consistent with previous findings, in the 
present study, treatment of castrates with estradiol failed to support SNB somal growth. 
Dendrites 
In untreated castrates, SNB dendritic lengths were significantly reduced compared with 
those of normal animals, replicating previous findings (Goldstein et al., 1990; Goldstein and 
Sengelaub, 1994; Nowacek and Sengelaub, 2006; Rudolph and Sengelaub, 2013a).  Our results 
also confirm the SNB target musculature as the site of action for estrogen-dependent dendrite 
growth during the early postnatal period (Nowacek and Sengelaub, 2006; Rudolph and 
Sengelaub, 2013a).  Previous work has demonstrated that the BC/LA binds estrogens (Dube et 
al., 1976) and extra-muscle fiber cells in the BC have been shown to express ERα in a 
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developmentally transient fashion (Rudolph and Sengelaub, 2013a).  The present study further 
demonstrates that ERα expression in BC extra-muscle fiber cells is also hormone-sensitive.  
Further, extra-muscle fiber ERα expression in the SNB target muscle coincides with the critical 
period for estrogen-dependent SNB dendrite growth, suggesting that this type of ERα expression 
could be important in mediating estrogen sensitivity of SNB motoneuron dendrites (Rudolph and 
Sengelaub, 2013a).  In this study, we show that castration results in a robust upregulation of 
extra-muscle fiber ERα at P21, and treating castrates with estradiol when ERα is upregulated in 
extra-muscle fiber cells results in SNB dendritic hypertrophy, despite the limited period of 
estradiol treatment.  In fact, given that estradiol can downregulate its own receptor quite rapidly 
(Baltgavis et al., 2010), the estrogen-treated castrated animals may have had elevated ERα for 
an even shorter period during the estradiol treatment.  Dendrite lengths of castrates treated with 
estradiol from P21 to P28 were significantly greater than those of normal males, and this 
enhanced dendritic growth occurred throughout the arbor.  The general hyper-responsiveness of 
SNB dendrites in castrates to estradiol treatment starting at P21 likely reflects the increase in 
extra-muscle fiber ERα expression in the SNB target muscle, as previous work has demonstrated 
that hormone receptor density in skeletal muscle fibers confers hormone sensitivity to 
motoneuron dendrites (Huguenard et al., 2011).  Changes in ERα density in the target 
musculature would necessarily affect SNB motoneurons as a whole, resulting in the increases in 
dendritic lengths throughout the arbor we observed.  Furthermore, given that alterations in 
afferent input can result in highly localized changes in SNB dendritic morphology (Hebbeler and 
Sengelaub, 2003), it is unlikely that the estrogen effects we observed were mediated by changes 
in specific estrogen-sensitive afferents. 
Comparability of HRP Labeling 
Previous studies have demonstrated that neither axonal transport of BHRP (Leslie et al., 
1991) nor dendritic transport as demonstrated by the rostrocaudal or mediolateral extent of 
dendritic labeling (Kurz et al., 1990; Goldstein and Sengelaub, 1994) is affected by hormone 
levels.  In the present study, the possibility that hormone manipulations could affect retrograde 
transport is an important consideration, as such artifact could potentially result in apparent 
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alterations in dendritic morphology.  No difference in rostrocaudal extents of SNB dendrites were 
observed, but radial extents in untreated castrates were smaller than those of normal males.  This 
result most likely reflects the attenuated growth of SNB dendrites rather than a transport artifact, 
which (because rostrocaudal extent was not affected) would necessarily have had to occur 
selectively in the transverse plane.  In contrast, no differences in either rostrocaudal or radial 
extents of dendrites were observed between normal males and estradiol-treated castrates, 
indicating that the ability of SNB dendrites to transport BHRP out to the most distal, highest order 
branches was not affected in these groups.  Thus, we believe the dendritic labeling across groups 
was comparable, allowing direct comparisons of dendritic length and distribution across groups. 
Mechanisms of Target-Mediated Dendritic Growth 
Hormone receptors in the SNB target muscle are important for the development of many 
features of the SNB system.  SNB motoneurons are spared from ontogenetic cell death 
perinatally by androgen action at androgen receptors (ARs) in the SNB target muscle (Freeman 
et al., 1996).  ERs in the SNB target muscle mediate the estrogen-dependent SNB dendrite 
growth (Nowacek and Sengelaub, 2006), a developmentally restricted process that coincides with 
ERα expression in extra-muscle fiber cells in the BC muscle (Rudolph and Sengelaub, 2013a).  
Furthermore, there is evidence of a causal relationship between hormone receptor expression in 
the target musculature and the degree of hormone sensitivity of the innervating motoneurons.  In 
rats, dendritic arbors of quadriceps motoneurons are androgen-insensitive, and castration with or 
without testosterone treatment does not affect dendrite lengths of these motoneurons (Huguenard 
et al., 2011).  When ARs are overexpressed in the skeletal muscle fibers of transgenic rats, 
dendrites of quadriceps motoneurons become androgen-sensitive: castration results in dendritic 
atrophy, and dendritic lengths of castrates return to normal lengths with testosterone treatment 
(Huguenard et al., 2011).  The experiments in this Chapter provides a developmental example of 
the relationship between changes in hormone receptor density in the target muscles of 
motoneurons and corresponding changes in hormone sensitivity of the dendrites of innervating 
motoneurons.  We have previously demonstrated that the density of ERα expression in extra-
muscle fiber cells in the BC muscle coincides with the period of estrogen sensitivity for SNB 
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dendrites (Rudolph and Sengelaub, 2013a).  In this set of experiments, we show that a 
castration-induced increase in extra-muscle fiber ERα in the developing SNB target muscle 
results in SNB dendrites that respond to brief estradiol treatment with robust dendritic 
hypertrophy.  Together, these data suggest that in multiple neuromuscular systems, the hormonal 
sensitivity of motoneuron dendrites is controlled by hormone receptor density in the target 
muscle. 
For estrogen-dependent dendrite growth in the SNB, the relationship between ERα 
density in the target musculature and estrogen sensitivity of SNB dendrites appears to involve 
ERα expression in a non-muscle fiber cell type.  ERα expression in muscle fibers does not 
change across development (Rudolph and Sengelaub, 2013a) or in response to removal of 
gonadal hormones by castration (present Chapter).  However, ERα expression in extra-muscle 
fiber cells in the SNB target muscle coincides with the period of SNB dendrite sensitivity and is 
also regulated by gonadal hormones.  These data suggest that these ERα-expressing extra-
muscle fiber cells have a critical role in the estrogen sensitivity of SNB motoneuron dendritic 
morphology during development.  Additionally, non-muscle fiber cells in the SNB target 
musculature have been suggested to be a critical mediator of androgen-dependent perinatal 
development of SNB cell number (Niel et al., 2009). 
It is clear that an extra-muscle fiber cell type in the SNB target muscle is critical for the 
masculinization of SNB morphology during development, but the specific identity of this cell type 
is unknown.  While the apparent lack of a basal lamina rules out several cell types (e.g., muscle 
fibers), other candidates (e.g., fibroblasts) remain.  Further, it is not known how estradiol 
promotes SNB dendrite growth through ERα in extra-muscle fiber cells in the target musculature.  
A likely mechanism is through the regulation of trophic factors that influence dendritic length.  For 
example, in adulthood, androgens regulate brain-derived neurotrophic factor (BDNF) in SNB 
motoneurons (Ottem et al., 2007; Verhovshek et al., 2010a), as well as in their target musculature 
(Verhovshek et al., 2010a), and androgen action at the target musculature regulates BDNF 
protein in SNB motoneurons (Verhovshek and Sengelaub, 2013).  The regulation of BDNF by 
androgen is critical for SNB dendritic morphology: supplying BDNF to cut axons after peripheral 
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axotomy restores soma size (Yang and Arnold, 2000) and dendritic length (Yang et al., 2004), 
while castration results in elevated muscle BDNF levels and dendritic atrophy which can be 
prevented by blockade of BDNF signaling (Verhovshek and Sengelaub, 2010).  Estradiol has 
been shown to regulate BDNF levels in vitro (Krizsan-Agbas et al., 2003) and in vivo (Solum and 
Handa, 2002), and BDNF-ERα coexpression occurs in developing neurons, providing a clear 
mechanism for estrogen regulation of BDNF (Solum and Handa, 2002).  Together, these data 
suggest that during the early postnatal period, estrogen-dependent SNB dendrite growth could 
occur through an estrogen-BDNF interaction in the SNB target muscle, and a target-mediated 
regulation of BDNF levels could be driving changes in SNB dendritic morphology. 
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CHAPTER 4: Maintenance of ERα in the SNB target muscle maintains estrogen sensitivity of 
SNB dendrites outside the early postnatal period 
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BACKGROUND 
We have previously demonstrated that the critical period for estrogen-dependent SNB 
dendrite growth is defined by the presence of ERα expression in BC extra-muscle fiber cells 
(Rudolph and Sengelaub, 2013a).  Further, the potential for SNB dendrites to grow in response to 
estrogen treatment appears to be determined by the density of extra-muscle fiber ERα in the SNB 
target muscle.  When ERα is downregulated in the SNB target muscle, the critical period for 
estrogen-dependent dendrite growth closes, rendering SNB dendritic morphology insensitive to 
estrogens.  However, early postnatal castration results in a marked upregulation of this extra-
muscle fiber cell ERα in the BC muscle.  If this castration-induced ERα upregulation is maintained 
outside of early development, the mechanism for estrogen-dependent dendrite growth is present, 
and dendritic morphology should respond to estradiol treatment allowing for estrogen-dependent 
SNB dendrite growth to occur outside the critical period for estrogen-dependent SNB 
dendrogenesis.  In this experiment, we test the hypothesis that maintenance of extra-muscle fiber 
cell ERα in the BC permits estrogen-dependent SNB dendrite growth outside of early 
development, when SNB dendrites are typically insensitive to estrogens. 
 
MATERIALS AND METHODS 
Animals.  Untimed pregnant rat dams (Sprague-Dawley; Harlan, Indianapolis, IN) were 
maintained on a 12-h light, 12-h dark cycle, with unlimited access to food and water.  Litters were 
culled to eight pups when necessary, retaining males preferentially.  To preserve ERα expression 
in the BC muscle (Rudolph and Sengelaub, 2013b), one group of males was bilaterally castrated 
on P7, and remained untreated until P28, when they had estradiol implants (see below) placed at 
the left BC muscle, remaining until P49 (n = 5); another group of males castrated on P7 were left 
untreated (n = 4).  Another group of males was castrated on P28, after ERα downregulation, and 
received daily systemic injections of estradiol benzoate (0.1 mg estradiol in sesame oil, sc; n = 3) 
from P28 to P49.  Age-matched intact control males (n = 5) were also used (overall n = 17).    All 
procedures were carried out in accordance with the NIH Guide for the Care and Use of 
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Laboratory Animals and approved by the Bloomington Institutional Animal Care and Use 
Committee. 
Implants.  To restrict hormone treatment to the SNB target musculature, we used our previous 
method (Nowacek and Sengelaub, 2006; Rudolph and Sengelaub, 2013a; Rudolph and 
Sengelaub, 2013b) to deliver estradiol locally to the BC muscle.  This treatment produces 
alterations in motoneuron morphology that can be directly ascribed to local rather than systemic 
effects; furthermore, the treatment has no effect on the typical development of SNB motoneurons, 
and no effect on dendritic labeling or tracer transport (Nowacek and Sengelaub, 2006; Rudolph 
and Sengelaub, 2013a; Rudolph and Sengelaub, 2013b).  Small (0.85 mm
3
) implants 
impregnated with estradiol (Steraloids, Newport, RI) were constructed by mixing crystalline 
estradiol with Silastic adhesive (Dow-Corning, Auburn, MI) and compressing the mixture between 
two glass slides (lightly greased with petroleum jelly) separated by a spacer (0.85 mm thick), and 
allowed to cure.  The cured Silastic was cut into 1 x 1 mm pieces (total volume 0.85 mm
3
) and 
coated on five sides with acrylic.  The amount of estradiol in each implant (0.1 mg) was similar to 
that used previously; this dosage does not produce systemic effects, and supports SNB dendritic 
growth (Nowacek and Sengelaub, 2006). 
Horseradish peroxidase conjugated to the cholera toxin β subunit (BHRP; List Biological, 
Campbell, CA) was used to retrogradely label SNB motoneurons innervating the BC muscle.  
Previous studies have demonstrated that BHRP labeling permits sensitive detection and 
quantitative analysis of SNB somal and dendritic morphologies (Kurz et al., 1986; Goldstein and 
Sengelaub, 1990; Hebbeler and Sengelaub, 2003).  SNB motoneuron morphology was examined 
at P49, (when SNB dendrites have reached their adult lengths; Goldstein et al., 1990).  At P47, 
animals were anesthetized, the perineal muscles exposed, and BHRP unilaterally injected (0.5 µl; 
0.2% solution) into the left BC muscle, the same muscle for those males that received muscle 
implants.  Forty-eight h after BHRP injection, a period that ensures optimal labeling of SNB 
motoneurons (Kurz et al., 1986; Goldstein et al., 1990), animals were given an overdose of 
urethane (0.5 ml/100 g body weight) and perfused intracardially with saline followed by cold 1% 
paraformaldehyde/1.25% glutaraldehyde fixative.  Lumbar spinal cords were removed, postfixed 
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in the same fixative for 5 h, and transferred to sucrose phosphate buffer (10% w/v, pH = 7.4) 
overnight for cryoprotection.  Spinal cord segments were then embedded in gelatin, frozen, and 
sectioned transversely at 40 µm; all sections were collected into four alternate series.  For 
visualization of BHRP, the tissue was immediately reacted using a modified tetramethyl benzidine 
protocol (TMB; Mesulam, 1982), mounted on gelatin-coated slides, counterstained with thionin, 
and cover-slipped with Permount.  BC/LA muscles were removed at perfusion and weighed to 
evaluate potential treatment effects on gross muscle development. 
The number of BHRP-filled motoneurons was assessed in all sections through the entire 
rostrocaudal extent of the SNB for all animals.  Counts of labeled motoneurons in the SNB were 
made under brightfield illumination, where somata and nuclei could be visualized and cytoplasmic 
inclusion of BHRP reaction product confirmed.  Estimates of the total number of labeled SNB 
motoneurons were obtained using the optical dissector method outlined by Coggeshall (1992) 
and a procedure similar to that of West and Gunderson (1990).  This method yields an unbiased 
count of SNB motoneurons (Raouf et al., 2000).  Counts were made at 500X; motoneuron 
somata could be easily visualized in multiple focal planes. BHRP-labeled motoneurons were 
counted as their somata first appeared in focus while focusing through the z axis, and labeled 
somata in the first focal plane (i.e., “tops”) were not counted.  For each animal, counts were 
derived from sections spaced at 160 µm intervals uniformly distributed through the entire 
rostrocaudal extent of the SNB. Within each section, all labeled somata within the SNB were 
counted.  Estimates of the total number of labeled SNB motoneurons were then obtained by 
correcting for percentage of the tissue sampled. 
The cross-sectional soma area of BHRP-labeled motoneurons was measured using a 
video-based morphometry system (Stereo Investigator; MBF Bioscience, Inc.) at a final 
magnification of 1350X.  Soma areas within each animal were averaged for statistical analysis.  
The optical density of labeled somata was also measured under brightfield illumination to confirm 
equivalence of BHRP labeling density. 
For each animal, dendritic lengths in a single representative set of alternate sections 
were measured under darkfield illumination.  Beginning with the first section in which BHRP-
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labeled fibers were present, labeling through the entire rostrocaudal extent of the SNB dendritic 
field was assessed in every other section (320 µm apart) in three dimensions using a computer-
based morphometry system (Neurolucida; MBF Bioscience, Inc.; final magnification 250X) to yield 
both composite illustrations of the arbor and measurements of individual fiber lengths.  All BHRP-
labeled fibers were drawn regardless of location, size, or contiguity with labeled cell bodies to 
ensure a complete assessment of dendritic length.  Because the entire rostrocaudal range of the 
SNB dendritic field in each animal was sampled, this method allows for a complete assessment of 
SNB dendrites in both the transverse and horizontal planes.  Average dendritic arbor per labeled 
motoneuron was estimated by summing the measured dendritic lengths of the series of sections, 
multiplying by two to correct for sampling, then dividing by the total number of labeled 
motoneurons in that series.  This method does not attempt to assess the actual total dendritic 
length of labeled motoneurons (Kurz et al., 1991), but has been shown to be a sensitive and 
reliable indicator of changes in dendritic morphology in normal development (Goldstein et al., 
1990), after hormonal or surgical manipulation (Kurz et al., 1986; Goldstein et al., 1990; Kurz et 
al., 1991; Goldstein and Sengelaub, 1994; Goldstein et al., 1996; Hays et al., 1996; Hebbeler and 
Sengelaub, 2003), due to dendritic interactions (Goldstein et al., 1993), or after NMDA receptor 
blockade (Hebbeler et al., 2002). 
Injections of BHRP into the left BC successfully labeled ipsilateral SNB motoneurons in 
all animals in a manner consistent with previous studies (Kurz et al., 1986; Goldstein and 
Sengelaub, 1990; Goldstein and Sengelaub, 1994; Burke et al., 1997; Burke et al., 1999; Fig. 
4.1).  SNB motoneurons displayed their characteristic multipolar morphologies, with dendritic 
arbors projecting ventrolaterally, dorsomedially, and across the midline into the area of the 
contralateral SNB (Fig. 4.1). 
 
RESULTS 
Soma size.  The size of SNB somata at P49 differed significantly across groups [F(3,13) = 3.96, 
p < 0.05; Fig. 4.2].  The mean cross-sectional area of SNB somata in intact control males (741.21 
± 22.93 µm
2
) was typical.  The somata of untreated castrates (697.86 ± 54.19 µm
2
) were not  
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Figure 4.1.  Darkfield digital images of transverse sections through the lumbar spinal cord of male 
rats at P49 showing labeled SNB motoneurons following injection of BHRP into the left BC 
muscles of a normal male (normal; top left), a male castrated on P7 and left untreated (castrate; 
top right), a male castrated at P28 and treated with estradiol  from P28 to P49 (P7 cast + E28-49; 
bottom left) , and a male castrated on P7 and treated with estradiol from P28 to P49 (P7 castrate 
+ E28-49; bottom right).  
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Figure 4.2.  Soma areas of SNB motoneurons at P49 for normal males, animals castrated on P7 
and left untreated (castrate), animals castrated at P28 and treated with estradiol  from P28 to P49 
(P7 cast + E28-49), and animals castrated on P7 and treated with estradiol from P28 to P49 (P7 
castrate + E28-49). Bar heights represent means ± SEM for three to five animals per group.  * 
significantly different from normal males. 
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different than those of normal animals.  Animals castrated on P7 and treated with estradiol from 
P28 to P49 (568.88 ± 44.84 µm
2
) had somata that were significantly reduced (23%) compared to 
those of normal animals (LSD, p < 0.05), and somata of P28 castrates treated with estradiol 
implants from P28-P49 (638.18 ± 13.77 µm
2
) had somata that were marginally significantly 
smaller (reduced 17%) than those of intact control males (LSD, p = 0.07). 
Dendritic lengths.  The overall length of SNB dendrites significantly differed across groups 
[F(3,13) = 5.50, p < 0.05; Fig. 4.3].  SNB dendritic length in intact control males was typical 
(4266.52 ± 519.32 µm).  Dendritic lengths in castrates were approximately 47% shorter (2278.51 
± 658.72 µm) than those of intact control males (LSD, p = 0.06).  Males castrated on P28 and 
treated with estradiol from P28-P49 had SNB dendritic arbors (1990.78 ± 278.85 µm) that were 
reduced 53% compared to those of intact control males (LSD, p = 0.05), and were not different 
than those of untreated castrates (LSD, p < 0.05).  P7 castrates treated with estradiol from P28-
P49 had dendritic lengths that were significantly greater than those of untreated castrates (LSD, p 
< 0.05, increased 159%) and P28 castrates treated with estradiol from P28-P49 (LSD, p < 0.05, 
increased 164%). 
 
DISCUSSION 
In this experiment we demonstrated that the early postnatal castration-induced maintenance 
of ERα in the SNB target muscle allows for estrogen-dependent SNB dendrite growth outside the 
early postnatal period.  This is the first demonstration that SNB dendritic morphology is estrogen-
sensitive after the first four postnatal weeks.  These results further demonstrate that the timing of 
early gonadal hormone exposure determines the sensitivity of the system to gonadal hormones 
later in development. 
Somata 
At P49, SNB somata of P28 castrates treated with estradiol from P28 to P49 were not 
different than those of intact animals.  The majority of somal growth occurs during the first four 
postnatal weeks (Goldstein et al., 1990), potentially explaining why castration at P28 did not 
affect the size of SNB somata at P49.  However, animals castrated on P7 and treated with  
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Figure 4.3.  Dendritic lengths expressed as length of arbor per labeled motoneuron of SNB 
motoneurons at P49 for normal males, animals castrated on P7 and left untreated (castrate), 
animals castrated at P28 and treated with estradiol  from P28 to P49 (P7 cast + E28-49), and 
animals castrated on P7 and treated with estradiol from P28 to P49 (P7 castrate + E28-49). Bar 
heights represent means ± SEM for three to five animals per group.  * significantly different from 
P7 castrates treated with estradiol from P28 to P49. 
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estradiol from P28 to P49 had somata that were significantly smaller than those of intact males.  
This effect can be explained due to the absence of androgen exposure from P7 to P49, as soma 
size is strictly androgenically regulated (e.g., Goldstein and Sengelaub, 1994), and also the 
effects of local estradiol treatment at the SNB target muscle, which has been shown to decrease 
soma sizes in castrated animals (Nowacek and Sengelaub, 2006; Rudolph and Sengelaub, 
2013a; Rudolph and Sengelaub, 2013b).  There was a trend towards a castration-induced 
decrease in SNB somata in all castrate groups, but untreated castrates had somata that were no 
different than those of gonadally intact males.  This can be explained by the greater variability in 
somata size in untreated castrates, and also the small number of animals (3-5) used per group in 
the analysis.  If more untreated castrates were added to the group, we expect that the typical 
castration-induced decrease in SNB soma size would be observed.  Importantly, the critical 
comparison for this experiment is SNB dendrite length, not soma size, and the patterns of change 
in SNB dendrites in response to castration and estradiol treatment follow the expected results.  
Further, it has been established that there is a disconnect between SNB soma size and dendritic 
length (e.g., Rudolph and Sengelaub, 2013a), so the failure to obtain a castration-induced 
decrease in SNB somata size does not confound the conclusions of this experiment. 
Dendrites 
Results demonstrated that preservation of muscle ERα via early castration resulted in 
estrogen-sensitive SNB dendrites outside of the critical period for estrogen-dependent SNB 
dendrite growth.  When males were castrated on P7, estrogen treatment from P28-P49 resulted 
in robust dendritic growth, and dendrite lengths of P7 castrates treated with estradiol from P28-
P49 were no different than those of age-matched intact control males.  However, when males 
were castrated on P28, after ERα in the muscle had downregulated, estradiol treatment from 
P28-P49 had no effect on SNB motoneuron dendrite growth, and dendrites of these animals were 
no different than those of untreated castrates.  Together, these results demonstrate that early 
castration creates estrogen-sensitive SNB dendrites by maintaining ERα in the muscle, allowing 
for estrogen-dependent dendrogenesis outside the critical period for SNB dendrite growth in 
response to estrogens.  Not only do SNB dendrites respond to estradiol when ERα is maintained 
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in the SNB target muscle, but they do so by growing during a time when SNB dendrites typically 
are also insensitive to estrogens.  Previous work has demonstrated that a castration-induced 
upregulation of ERα in the SNB target muscle results in hypersensitivity of SNB dendrites to 
estradiol during the early postnatal period, but this is the first demonstration that SNB dendrites 
grow in response to estrogens after P28.  The current findings build upon earlier data establishing 
the relationship between extra-muscle fiber ERα in the BC and SNB dendrite estrogen sensitivity 
(Rudolph and Sengelaub, 2013b), and demonstrate that the castration-induced upregulation of 
ERα in the muscle extends the critical period for estrogen-dependent SNB dendrite growth. 
 
CONCLUSIONS 
These findings further substantiate the SNB target muscle as the critical site of action for the 
influence of gonadal hormones on SNB motoneuron morphology.  Hormone receptor density has 
been shown to confer hormone sensitivity to motoneurons previously (Huguenard et al., 2011).  
These findings extend the importance of the muscle-based receptor—motoneuron sensitivity 
relationship to demonstrate the mechanism for shifting a critical period for estrogen-dependent 
SNB dendrite growth: is hormone receptor expression in the SNB target muscle.  The current 
study demonstrated that estrogen-dependent dendrite growth occurs outside of P28, but it is 
unclear how long SNB dendrites remain estrogen sensitive after castration on P7.  We have 
shown that this early castration upregulates extra-muscle fiber ERα at P21, but it is unknown if 
this castration-induced upregulation is stable for an extended period of time.  Future studies 
should determine the time course of castration-induced estrogen sensitivity of SNB motoneuron 
dendrites by delaying post-castration estradiol treatment until adulthood to see if the critical 
period for estrogen-dependent SNB dendrite growth can be extended indefinitely. 
Castration prior to the developmental downregulation of extra-muscle fiber ERα maintains the 
sensitivity of SNB dendrites, but it is unclear why the developmental downregulation of ERα 
occurs during typical development.  We have posited that high estrogen levels during early 
postnatal life drive down ERα expression in the SNB target muscle, but this hypothesis has not 
been directly tested.  Castration prevents the developmental decline in ERα, demonstrating that 
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the removal of the gonad triggers a change in ERα in the muscle, which does not eliminate the 
possibility that other gonadal steroids are responsible for alterations in ERα expression in the 
SNB target muscle.  Testosterone or its androgenic metabolite, dihydrotestosterone could also be 
involved in the regulation of ERα in the muscle, and castration-induced changes in muscle ERα 
could be mediated by androgens, not estrogens.  Additionally, sex hormone binding globulin 
(SHBG) production occurs in the testes, and removal of the gonads by castration could alter 
SHBG levels thereby changing circulating levels of androgens and estrogens to modulate muscle 
ERα levels.  SHBG is present in developing rat skeletal muscle (Becchis et al., 1996), and has 
been shown to mediate activation of AR and ERs (Kahn et al., 2008), indicating that changes in 
muscle ERα could be occurring directly or indirectly through the regulation of SHBG. 
Regardless of the mechanism of castration-induced changes in extra-muscle fiber ERα, it is 
clear that ERα in the BC mediates estrogen-dependent dendrite growth, and can do so outside of 
early development.  This finding is important for understanding the relationship between 
developmental gonadal hormone profiles and neural sensitivity to gonadal hormones in later 
development and adulthood.  Although castration does not capture an ecologically relevant 
alteration in circulating gonadal hormone levels, it is likely that more subtle, natural changes in 
gonadal hormones during masculinization will affect the sensitivity of gonadal hormone-sensitive 
structures later in development.  Future studies should address how natural shifts in androgens 
and estrogens can prime the neuraxis for hyper- or hyposensitivity of neural structures to these 
same hormones during adolescence and adulthood. 
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CHAPTER 5: ERα is not localized within satellite cells in the SNB target muscle during early 
development
 67 
 
BACKGROUND 
As demonstrated in previous Chapters, the transient period of peripherally-mediated, 
estrogen-dependent SNB dendrite growth is defined by a change in ERα expression at the target 
musculature.  ERα expression in extra-muscle fiber cells is greatest during the period of 
estrogen-dependent dendrite growth, but declines significantly, and is low or absent when SNB 
dendrites are insensitive to estrogens (Rudolph and Sengelaub, 2013a; Chapter 2). Furthermore, 
restricting estradiol treatment at the BC muscle to the period when extra-muscle fiber cell ERα 
expression is greatest results in complete masculinization of SNB dendrites (Rudolph and 
Sengelaub, 2013a; Chapter 2).  The location of expression within the BC muscle is particularly 
important: ERα expression in extra-muscle fiber cells parallels the estrogenic sensitivity of SNB 
dendrites, whereas there is no change in muscle fiber ERα across development.  Additionally, 
just as gonadal hormones regulate SNB dendritic morphology, they alter BC extra-muscle fiber 
cell ERα expression, which is dramatically upregulated following castration (Rudolph and 
Sengelaub, 2013b; Chapter 3).  However, no castration-induced changes in muscle fiber ERα are 
observed, suggesting that ERα expression in extra-muscle fiber cells but not within muscle fibers 
mediates the estrogen sensitivity of SNB dendrites (Rudolph and Sengelaub, 2013b; Chapter 3).  
Also, the castration-induced upregulation of BC extra-muscle fiber ERα preserves estrogen 
sensitivity of SNB dendrites, and one week of estradiol treatment is sufficient to fully masculinize 
SNB dendritic morphology when the period of estrogen treatment coincides with heightened BC 
extra-muscle fiber ERα expression (Rudolph and Sengelaub, 2013b; Chapter 3).  Together, these 
data demonstrate that the critical period for estrogen-dependent SNB dendrogenesis is defined 
by ERα expression in BC extra-muscle fiber cells, and these ERα-expressing BC cells appear to 
mediate estrogen sensitivity of SNB dendrites during the early postnatal period.  
This is not the first example of hormone receptor expression in extra-muscle fiber cells 
controlling masculinization of SNB features. The sex difference in SNB cell number occurs 
through the actions of perinatal androgens: in males, motoneurons are spared from cell death by 
androgen action through androgen receptors (ARs), presumably in the BC muscle (Fishman et 
al., 1996).  In females without sufficient androgens, more motoneuron death occurs, resulting in a 
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smaller, feminine SNB.  ARs are required for the rescue of SNB motoneurons from death, and the 
location of AR in the BC muscle appears to be critical for masculinization of SNB cell number as 
well.  However, in a transgenic animal expressing androgen receptors (ARs) solely within muscle 
fibers, the SNB motoneurons were female in number and size, demonstrating that AR expression 
within muscle fibers is not sufficient to mediate masculinization of the SNB (Niel et al., 2009).  
Recent evidence shows that AR-expressing satellite cells are present in the LA during the period 
when androgens act at the SNB target muscle to spare motoneurons from cell death (Swift-
Gallant and Monks, 2013).  Additionally, satellite cells in the SNB target muscle are regulated by 
androgens: testosterone treatment increases satellite cell number in the LA, implicating these 
cells as an androgen target during early development (Niel et al., 2008).  Similar to the role of AR 
in androgen regulation of SNB motoneuron number, ERα expression that appears to mediate 
estrogen-dependent masculinization of SNB dendrites occurs in BC non-muscle fibers.  Because 
ERα expression has previously been demonstrated in satellite cells of skeletal muscle (Kalbe et 
al., 2007), we hypothesized that ERα expression in satellite cells during the period of estrogen-
dependent masculinization of SNB dendrites will occur. 
 
MATERIALS AND METHODS 
Animals.  Untimed pregnant rat dams (Sprague-Dawley, Harlan, Indianapolis, IN) were 
maintained on a 12-h light, 12-h dark cycle, with unlimited access to food and water.  When 
pregnant females gave birth (day of birth = P1), pups were sexed and litters were culled to eight 
pups when necessary, retaining males preferentially.  All procedures were carried out in 
accordance with the NIH Guide for the Care and Use of Laboratory Animals and approved by the 
Bloomington Institutional Animal Care and Use Committee. 
Immunohistochemistry.  Immunohistochemistry was performed largely according to the 
methods used previously (Rudolph and Sengelaub, 2013a; Rudolph & Sengelaub, 2013b; 
Chapters 2-3).  At P14, when extra-muscle fiber ERα levels are high (Rudolph and Sengelaub, 
2013a), animals (n = 5) were weighed, given an overdose of urethane (0.25 g/100 g of body 
weight), and perfused transcardially with 0.9% saline followed by cold 4% paraformaldehyde in 
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0.1M phosphate buffer (pH = 7.4).  The BC/LA muscles were removed and postfixed in the same 
fixative for 24 h and transferred to 30% sucrose in 0.1M phosphate buffer for a minimum of 24 h 
of cryoprotection.  The BC/LA was cut horizontally into 12 μm sections on a cryostat at -16°C.  
Sections were thaw-mounted onto gelatin-coated slides, and stored at -16°C.  For 
immunohistochemical processing, slides were brought to room temperature, and rinsed 3 x 5 min 
in phosphate buffered saline (PBS, pH 7.4).  After rinsing, a hydrophobic border (Super Pap Pen, 
Ted Pella, Inc., Redding, CA) was created around each tissue section.  All incubations occurred 
in a humidified chamber and were performed by pipetting 200 μl of solution onto each section. 
Sections were incubated for 45 min at room temperature in blocking solution containing 
10% normal goat serum (NGS; Vector Laboratories, Inc., Burlingame, CA) and 10% normal horse 
serum (NHS, Vector Laboratories, Inc.) 0.24% Triton X-100 in PBS.  Sections were then 
incubated for 48 h at 4ºC in 4% NGS and 4% NHS with 0.276% Triton X-100 in PBS containing 
an antibody directed against the last 14 amino acids of the rat ERα (C1355, 1:1000; Millipore, 
Temecula, CA) and an antibody that labels satellite cells (PAX7, concentrate antiserum, 1:200, 
Developmental Studies Hybridoma Bank, Iowa City, IA).  Slides were rinsed with PBS, and 
avidin-biotin (Vector), and washed with PBS, followed by a two hour incubation in secondary 
antibodies (goat anti-rabbit Alexa Fluor 488 F(ab’)2 fragments (H+L), 1:200; Invitrogen, Eugene, 
OR; rat adsorbed affinity purified biotinylated horse anti-mouse IgG, 1:200).  Slides were washed 
3 x 5 minutes in PBS and incubated for 1 hour in Cy3-conjugated streptavidin (1:5000, Jackson 
ImmunoResearch Laboratories Inc., West Grove, PA).  Slides were washed 3 x 5 min in PBS, 
briefly dried, and coverslipped with Vectashield hard set mounting medium with DAPI (H-1500, 
Vector Laboratories).  Slides were laid flat to dry for 5 minutes, sealed with nail polish (Deep 
Purple, Target, Minneapolis, MN), and dried at room temperature for 10-15 minutes, and laid flat 
to dry overnight at 4°C, and then stored in black boxes at 4C until microscopic analysis.  To 
control for nonspecific staining, control sections incubated without both primary antibodies were 
generated and demonstrated no immunostaining. 
Microscopic Analysis.  Images were captured using a Leica SP5 laser scanning inverted 5-
channel confocal microscope (Leica Microsystems, Buffalo Grove, IL).  For each animal, 2-3 
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sections (mean = 2.2) and 3-6 fields (mean = 4.5) were sampled.  A minimum of 15 satellite cells 
were required for a field to be included in the analysis.  Initial analysis of images was performed 
using LAS-AF LITE software, and images were exported to Photoshop (Adobe) for further 
analysis. ERα label (green; FITC) and PAX7 label (red; Cy3) were clearly visible in each field 
(Fig. 5.1).  All PAX7-labeled cells were counted for each captured image, and partial cells were 
excluded from the total number of PAX7-positive cells for each field.  ERα label and PAX7 label 
clearly occupied distinct space in the captured images.  To ensure that ERα and PAX7 labels 
were not colocalized, stacks of images from the z-axis were compiled to create a 3-dimensional 
image, and these z-stacks demonstrated no colocalization of ERα  
 
RESULTS 
In an average of 145.6 ± 6.14 (SEM) PAX7-labeled satellite cells per animal, no 
colocalization of ERα and PAX7 was observed (Fig. 5.2). 
 
DISCUSSION 
These data demonstrate that at P14, ERα expression does not occur within satellite cells 
in the BC muscle, as no evidence of PAX7-ERα colocalization was observed.  This suggests that 
the ERα-expressing extra-muscle fiber cells in the BC that are critical for estrogen-dependent 
SNB dendrite growth are not satellite cells.  It is possible that colocalization of ERα and PAX7 
occurs in the SNB target muscle, and it was not observed due to undersampling.  Previous work 
using double-labeled immunofluoresence in the SNB target muscle concluded an absence of 
colocalization of AR and fibroblast label in two experimental groups sampling an average of 94.5 
and 69.5 cells of interest (Swift-Gallant and Monks, 2013; Fig. 5.1).  In this experiment 
significantly more cells of interest were analyzed and no colocalization occurred.  For this reason, 
I am confident in concluding that these data demonstrate that the label of interest (ERα) is not 
localized within the cells of interest (satellite cells). 
Because the ERα-extra-muscle fiber cells in the BC muscle are not satellite cells, future 
studies should determine what cell type they are.  Fibroblasts are one candidate cell type, as they  
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Figure 5.1.  Representative confocal image of BC muscle at P14 displaying ERα (green) and 
PAX7 immunolabeling (red).  ERα expression does not occur within satellite cells (identified by 
PAX7 labeling). 
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Figure 5.2.  Combined data from the current study (right) and a previous study (left bars) 
assessing colocalization of ERα and AR (respectively) in the developing SNB target muscle.  AR 
is localized within satellite cells (PAX7+; yellow) in the SNB target muscle, but not in fibroblasts 
(S100A4+ cells).  ERα was not localized within satellite cells in the developing SNB muscle. 
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are found in higher levels during development, when we have observed extra-muscle fiber ERα.  
While it is promising that the extra-muscle fiber ERα expression profile might parallel that of 
fibroblast expression in the developing muscle (e.g., high during early development, decreasing  
through late development), it is unknown whether the developmental downregulation of extra-
muscle fiber ERα is due to the loss of ERα-expressing cells in the muscle, or a decrease in ERα 
without a change in cell type expressing ERα.  Other data suggesting fibroblasts are a good 
extra-muscle fiber cell type candidate demonstrate that  AR expression occurs within fibroblasts 
of the SNB target muscle in mice (Johanson et al., 2007) and rats (Monks et al., 2004).  How 
castration affects fibroblast profiles or if SNB target muscle fibroblasts express ERα should be 
assessed to determine if fibroblasts remain a likely candidate cell type for the ERα-expressing 
cells that mediate estrogen-dependent SNB dendrite growth. 
Another possible cell type that could express ERα during early SNB development is 
terminal Schwann cells.  Terminal Schwann cells are present in muscle in high densities at the 
neuromuscular junctions and play an important role in neuromuscular physiology.  Similar to 
ERα-expressing extra-muscle fiber cells, terminal Schwann cell densities are very high in the 
developing SNB target muscle and decrease with age (Love and Thompson, 1998).  Further, 
terminal Schwann cells are sensitive to gonadal hormone manipulation: castration reduces 
terminal Schwann cell density, and testosterone treatment restores terminal Schwann cell levels 
to those of gonadally intact animals both in adulthood (Lubischer and Bebinger, 1999) and 
development (Jordan and Williams, 2001).  However, AR is not found in terminal Schwann cells 
of the SNB target muscle (Monks et al., 2004), so androgenic regulation of terminal Schwann cell 
number must occur indirectly.  Further, ERα expression in terminal Schwann cells has not been 
demonstrated.  Future studies should investigate the potential for terminal Schwann cells in BC 
muscle to express ERα. 
Adipocytes are another cell type that could be involved in estrogen-dependent SNB 
dendrite growth.  Adipocytes have been shown to express ERα in human fetal adipose tissue 
(Velickovic et al., 2014) suggesting the possibility that ERα can be expressed in adipocytes in rat 
skeletal muscle, although this remains to be determined.  Gonadal hormones regulate many 
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features of adipocyte structure and function.  For example, in adult mice, castration results in 
changes in adipocyte AR expression (Floryk et al., 2011).  While the effects of castration on ERα 
expression in adipocytes are unknown, the potential for adipocytes to be the ERα-expressing 
extra-muscle fiber cells involved in estrogen-dependent dendrite growth remains. 
Although the current data have ruled out satellite cells in the SNB target muscle as the 
extra-muscle fiber cells critical for estrogenic dendrogenesis during early postnatal development, 
fibroblasts and terminal Schwann cells, and to a lesser extent, adipocytes, are promising potential 
extra-muscle fiber cell types.  Future studies should assess the potential localization of ERα 
within these muscle cell types and should determine if these cell types are sensitive to gonadal 
hormones and indeed are the site of action for estrogen-dependent SNB dendrite growth. 
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CHAPTER 6: Effects of early castration and estradiol treatment on BDNF levels in SNB 
motoneurons and the SNB target musculature  
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BACKGROUND 
During early development, SNB motoneuron dendrites undergo robust dendritic growth in 
response to estrogens.  Estrogen-dependent SNB dendrite growth is transient (Nowacek and 
Sengelaub, 2006), and restricted to the early postnatal period when ERα is expressed in high 
densities in extra-muscle fiber cells of the SNB target muscle (Rudolph and Sengelaub, 2013a, 
2013b; Chapter 2).  This ERα expression profile is sensitive to gonadal hormones, and castration 
results in a marked elevation of ERα with a coincident increase in the estrogen responsivity of 
SNB dendrites (Rudolph and Sengelaub, 2013b; Chapter 3).  Although we understand the 
relationship between ERα in the SNB target muscle and the estrogen sensitivity of SNB 
motoneuron dendrites, the mechanisms responsible for these development- and castration-
induced changes in ERα remain unknown.  Conversely, the molecular mechanisms of androgen-
dependent influences on SNB dendrites in adulthood have been investigated and involve brain-
derived neurotrophic factor (BDNF), so it is possible that the same mechanisms that underlie the 
maintenance of androgen-dependent of adult SNB motoneuron morphology also control 
estrogen-dependent changes in SNB motoneurons during development.  Further, BDNF has 
been shown to play a role in hormone-mediated masculinization of the SNB during early 
development (motoneuron number; Xu et al., 2001), and estrogen-BDNF interactions regulate 
dendritic morphology across the neuraxis.  These data suggest that estrogen can regulate BDNF 
in the same manner as androgens in the SNB system, and demonstrate that estrogen-dependent 
dendrite growth could be mediated by changes in muscle BDNF.  To determine if BDNF is 
affected by alterations in gonadal hormones during the period of estrogen-dependent dendrite 
growth, we assessed BDNF levels in SNB neuromuscular system after castration and estradiol 
treatment during the early postnatal period, when estradiol treatment results in robust SNB 
dendrogenesis.  BDNF levels were measured in SNB motoneurons (using immunohistochemistry) 
and the SNB target muscle (using ELISA) in castrates, castrates treated with estradiol implants 
placed interscapularly, castrates treated with estradiol implants at the SNB target muscle, 
castrates treated with blank implants at the SNB target muscle, and intact control males. 
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Experiment 1 
MATERIALS AND METHODS 
BDNF Immunohistochemistry.  On postnatal day 7 (P7) male rats were bilaterally castrated 
under isoflurane anesthesia.  Some castrates received estradiol implants (0.1 mg) at the left BC 
muscle (n = 6), some received similar estradiol implants placed in the interscapular region (n = 4), 
some received implants without hormone that were placed at the left BC muscle (blank implants; 
n = 5) and some were left untreated (n = 5).  Another group of males remained gonadally intact (n 
= 4).  On P21, animals were weighed, overdosed with urethane (0.25 g/100 g body weight), and 
perfused intracardially with 0.1 M sodium phosphate buffer followed by cold 4% 
paraformaldehyde in 0.1M sodium phosphate buffer (pH = 7.2).  The lumbar segment (L5-S1) of 
cord was postfixed individually in the same fixative for 18 h and then transferred to 30% sucrose 
in 0.1M sodium phosphate buffer (pH = 7.4) overnight for cryoprotection.  The following day, 
spinal cords were sectioned horizontally at 30 µm and stored in 0.1 M sodium phosphate buffer.  
Sections were rinsed with 0.01M PBS and incubated 30 min in 0.5% hydrogen peroxide in a 
blocking solution containing 1% normal goat serum and 0.1% Triton X-100 in 0.01M PBS, 
followed by 1 h in blocking solution without hydrogen peroxide.  Sections were then incubated 48 
h at 4°C in rabbit anti-BDNF primary antibody (1:1000, AB1779; Millipore, Temecula, CA) 
followed by 24 h incubation in biotinylated goat anti-rabbit secondary antibody (1:200; Vector 
Laboratories, Burlingame, CA).  Antibody signal amplification was achieved with an ABC reaction 
(Vector Standard Elite Kit) and visualized with 0.035% diaminobenzidine and 0.006% H2O2.  
Sections were mounted onto gelatin-coated slides, defatted, and coverslipped. 
A semi-quantitative method of categorizing cells as intensely, moderately, or lightly 
immunolabeled was used (Osborne et al., 2007; Verhovshek et al., 2010a).  SNB motoneurons 
were identified by their characteristic medial location in the L5-S1 spinal segment, and their large, 
multipolar somata (Fig. 6.1).  Regardless of immunostaining density, the optical density of all 
identified SNB somata were measured (Stereo Investigator, MBF Bioscience, Inc.) as average 
luminosity per pixel (in 256 shades of gray, where black = 0 and white = 256) at a final 
magnification of 1480X under bright field illumination.  To control for differences in  
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Figure 6.1. Digital light micrographs of horizontal sections of regions of the spinal cord containing 
BDNF immunolabeled SNB motoneurons from a gonadally intact male at P21.  (A) Lower 
magnification illustrating the medial location of SNB motoneurons.  Inset indicates higher 
magnification image of SNB motoneurons shown in (B).  Scale bars = 100 µm.  
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immunostaining across sections and animals, optical density measures within each section were 
expressed relative to immunostaining in the adjacent white matter.  BDNF immunostaining in 
white matter does not vary with hormonal condition using this immunolabeling protocol 
(Verhovshek and Sengelaub, 2013).  Immunolabeled somata were categorized as intensely, 
moderately, or lightly labeled, according to their optical density values compared to mean optical 
density of BDNF immunolabeled somata in intact control males.  This method of immunolabel 
quantification does not attempt to assess the actual amount of BDNF in motoneurons, but 
provides a reliable method for categorizing cells by immunostaining for subsequent analyses 
(Verhovshek and Sengelaub, 2010b). 
 
RESULTS 
The optical density of an average of 64.96 + 4.67 SNB motoneuron somata was 
assessed over an average of 3.08 ± 0.20 sections per animal.  In normal males, the mean of the 
relative optical density of SNB motoneuron somata immunolabeled for BDNF was 0.80 with a 
standard deviation of 0.11.  Intensely immunolabeled somata comprised 19.5% of the population, 
moderately immunolabeled somata comprised 60.4% of the population, and lightly 
immunolabeled somata comprised the remaining 20.1% of the population of SNB somata.  BDNF 
immunolabeling was not significantly changed in response to hormonal condition [F(4,38) = 1.75, 
n.s.; Fig. 6.2].  In untreated castrates compared to normal males, there was a moderate, non-
significant decrease in the proportion of intensely labeled cells (4.2%) while the proportion of 
moderately labeled SNB somata was similar (64.8%), and there was a non-significant increase 
(31%) in the proportion of lightly labeled cells [F(1,14) = 1.53, n.s.].  Castrates treated with 
estradiol at the BC muscle had proportions of intensely (13.4%), moderately (72.7%) and lightly-
labeled (13.9%) somata that did not differ from those of castrated males [F(1,18) = 2.22, n.s.].  
Castrates treated with estradiol at the interscapular region had proportions of intensely- (1.6%), 
moderately- (75.32%), and lightly-labeled (8%) somata that were comparable to those of 
untreated castrates [F(1,14) = 3.07, n.s.] and castrates treated with estradiol at the BC muscle 
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Figure 6.2.  BDNF-immunolabeled SNB somata at P21 in normal males, untreated castrates 
(castrate), castrates treated with estradiol implants from P7-21 at the BC (castrate + EBC), 
castrates treated with interscapular estradiol implants from P7-21 (castrate + Escap), and castrates 
treated with a blank implant at the BC from P7-21 (cast + blankBC).  Percentages of lightly-, 
moderately, and intensely-immunolabeled SNB somata did not differ across groups.
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[F(1,16) = 0.22, n.s.].  Castrates treated with blank implants at the BC muscle had a proportions 
of intensely (8.2%), moderately (54.7%), and lightly labeled (34.12%) somata that were similar to 
those of untreated castrates [F(1,16) = 0.29, n.s.].The mean cross-sectional area of SNB somata 
was not different across groups [F(4,19) = 0.49, n.s.]. 
 
Experiment 2 
MATERIALS AND METHODS 
BDNF ELISA.  On P21, two weeks after hormonal manipulations, animals were euthanized by 
rapid decapitation.  BC muscles were immediately removed, weighed, snap frozen on dry ice, 
wrapped in foil, transferred to polypropylene microcentrifuge tubes, and stored at -80°C.  On the 
day of homogenization, 5 µl protease inhibitor cocktail (P8340; Sigma, St. Louis, MO, USA) was 
added to each ml of prepared homogenization buffer (100mM Tris HCl, pH 7, 2% BSA, 1M NaCl, 
4mM EDTA, 2% Triton X-100, 0.1% sodium azide).  Muscles were cut into small (~ 1 mm) pieces 
and placed in cold homogenization buffer (50 mg wet weight muscle per ml).  Muscle was 
thoroughly homogenized using a rotor-stator homogenizer and homogenates were kept on ice 
until centrifugation (3200g, 30 min, 4°C).  Resulting supernatants were transferred to 
polypropylene microcentrifuge tubes and stored at -80°C.  On the day of the BDNF assay, frozen 
supernatants were thawed, briefly vortexed, and re-centrifuged (14000g, 30 min, 20°C) before 
analysis.  Samples were diluted 1:4 in sample diluent and run in duplicate using a single 
commercial BDNF ELISA kit (CYT306, EMD Millipore, Billerica, MA, USA) according to the 
manufacturer’s instructions.  The following protocol parameters were used: overnight incubation 
was performed at 5°C with no shaking, mouse anti-BDNF incubation took place for 3 h on a 
shaker plate (200 rpm), and streptavidin-HRP incubation was performed with shaking (200 rpm).  
Following addition of the stop solution, optical density was read immediately at 450 nm (Epoch 
microplate spectrophotometer, BioTek Instruments, Inc., Winooski, VT, USA).  Final BDNF 
concentrations were calculated using a linear regression model (Gen5 Data Analysis Software, 
BioTek) and data were expressed relative to the wet muscle mass (pg BDNF/mg tissue).  Assay 
sensitivity was 7.8 pg/ml and intra-assay variation averaged 3.46% (range, 0.3 to 10.8).  The 
assay was validated for parallelism by comparing a serial dilution of pooled muscle homogenate 
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to the BDNF standard curve (r
2
 = 1.0).  Recovery of known amounts of BDNF standard added to 
a pool of muscle homogenate was 114.3 ± 5.2% (y = 0.98x + 11.2; r
2 
= 0.98).  Because changes 
in BDNF concentration might be secondary to changes in overall protein levels in the muscle, we 
determined if castration and estradiol treatment affected total protein levels in the BC muscle.  
Total protein was measured in muscle homogenates using a microplate colorimetric assay (DC 
Protein Assay II, Bio-Rad, Hercules, CA, USA) according to the manufacturer’s instructions, 
creating standards of 1.43, 0.715, 0.3575, and 0.17875 mg/ml for the curve.  Samples were 
further diluted 1:25 in ultrapure water before analysis.  As recommended by the manufacturer, 
standard curves were prepared in both the original sample matrix (Millipore BDNF sample diluent) 
and ultrapure water.  Resulting absorbance values for each standard concentration were plotted 
using a linear regression model (Gen5) and the standard curves for sample diluent versus 
ultrapure water were compared to confirm the absence of assay interference by the sample 
diluent (r = 0.9).  Total protein concentrations for each sample were then calculated using the 
standard curve prepared with sample diluent. Intra- assay CV averaged 3.9% (range, 0.5 to 9.09). 
 
RESULTS 
BDNF levels varied significantly across groups [F(4,23) = 4.65; Fig. 6.3].  Compared to 
intact control males (1.97 ± 0.14 pg/mg), BDNF levels were significantly greater in untreated 
castrates (2.85 ± 0.18 pg/mg; increased 45%), castrates treated with estradiol at the BC muscle 
(3.27 ± 0.28 pg/mg), or interscapular region (3.07 ± 0.22 pg/mg), and castrates with a blank 
implant at the BC muscle (2.62 ± 0.25 pg/mg; LSDs p < 0.05).  These data demonstrate that 
castration results in an increase in BDNF in the BC muscle.  BDNF levels in castrates treated with 
estradiol, regardless of treatment location, had BDNF levels that were no different than those of 
untreated castrates or castrates with a blank implant at the muscle, demonstrating that estradiol 
has no effect on BDNF levels in the SNB target muscle during the early postnatal period.  There 
was no difference in total protein in the BC across groups [F (4,23) = 1.43; Fig. 6.4].  Because 
protein in the BC muscle was not affected by castration, as BDNF levels were, these data  
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Figure 6.3.  BDNF levels in the BC muscle at P21 in normal males, untreated castrates (castrate), 
castrates treated with estradiol implants from P7-21 at the BC (castrate + EBC), castrates treated 
with interscapular estradiol implants from P7-21 (castrate + Escap), and castrates treated with a 
blank implant at the BC from P7-21 (cast + blankBC).  * significantly different from normal males.  
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Figure 6.4.  Protein levels in the BC muscle at P21 in normal males, untreated castrates 
(castrate), castrates treated with estradiol implants from P7-21 at the BC (castrate + EBC), 
castrates treated with interscapular estradiol implants from P7-21 (castrate + Escap), and castrates 
treated with a blank implant at the BC from P7-21 (cast + blankBC). 
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demonstrate that the castration-induced change in BDNF is due to increases in BDNF itself, and 
not to changes in overall protein levels in the muscle. 
 
DISCUSSION 
In the experiments of this Chapter, I determined the effects of castration and estrogen 
treatment on BDNF levels in SNB motoneurons and their target muscles during the 
developmental period when estrogen-dependent SNB dendrite growth occurs.  Results 
demonstrate that BDNF immunolabeling in SNB motoneurons does not change in response to 
castration or estradiol treatment, as the relative frequency of lightly, moderately, and intensely 
labeled SNB somata did not differ significantly across treatment groups.  In the BC muscle, there 
was a significant increase in BDNF levels following castration, and neither a blank implant at the 
BC muscle or estradiol treatment (interscapular or at the BC) affected the castration-induced 
increase in muscle BDNF levels.  Together, these data demonstrate that castration affects BDNF 
levels in the SNB target muscle, but not in motoneurons and that regardless of the castration 
effects on BDNF in the SNB neuromuscular system, estradiol treatment of castrates, whether 
interscapular or at the BC muscle, has no effect on BDNF immunolabeling in motoneurons, or 
BDNF protein in the BC muscle.  This suggests that estrogen-dependent SNB dendrite growth 
does not occur through changes in BDNF in SNB motoneuron somata during the early postnatal 
period, as muscle and motoneuron BDNF did not change in response to estradiol treatment when 
estradiol is promoting dendrogenesis in SNB motoneurons. 
BDNF immunolabeling 
In this experiment, I found that in postnatal development the proportion of SNB somata 
lightly, moderately, and intensely immunolabeled for BDNF did not change significantly in 
response to castration or estradiol treatment (interscapular or at the BC muscle).  These results 
are in contrast to previous results finding that in adulthood, castration results in a significant shift 
in BDNF immunolabeling in SNB somata: the percentage of intensely labeled somata decreases, 
with a concomitant increase in the percentage of somata lightly labeled for BDNF (Verhovshek et 
al., 2010a).  Interestingly, there is a non-significant trend in the current data that follow the results 
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found in adulthood: castration moderately increases the proportion of lightly labeled somata while 
decreasing the proportion of SNB somata that are intensely labeled for BDNF.  This shift in 
intensely to lightly immunolabeled somata follows the same pattern of results observed in 
adulthood after castration.  Further, there is a non-significant trend in the current data that 
estradiol treatment at the BC restores BDNF immunolabeling to the levels observed in gonadally 
intact animals, suggesting that estradiol treatment at the SNB target muscle affects BDNF levels 
in SNB motoneurons, and that estrogen-dependent SNB dendrite growth could be mediated by 
changes in somal BDNF during the early postnatal period.  Curiously, BDNF immunolabeling in 
castrates treated with interscapular estradiol is similar to that of castrates receiving estradiol 
treatment at the BC muscle.  One explanation for these data is that the interscapular estradiol 
dose was too high, causing systemic elevations in estradiol that acted through the SNB target 
muscle.  Previous data has demonstrated that gonadal hormone regulation of BDNF 
immunolabeling in SNB somata occurs through hormone action at the SNB target muscle 
(Verhovshek and Sengelaub, 2013), so excess estradiol from interscapular implants could act at 
the BC muscle to cause changes in BDNF immunolabeling in SNB somata that mimicked those 
found in castrates treated with estradiol at the BC muscle.  However, interscapular implants 
containing an identical amount of estradiol do not alter SNB dendritic morphology in castrates 
(Nowacek and Sengelaub, 2006; Rudolph and Sengelaub, 2013a; Rudolph and Sengelaub, 
2013b).  Because the same estradiol interscapular treatment alters BDNF immunolabeling in SNB 
somata but has no effect on promoting SNB dendritic morphology, this change in somal BDNF 
cannot be responsible for any effects on SNB motoneuron dendrite growth.  Therefore, the small 
but not significant alterations in BDNF immunolabeling observed in castrates treated with 
interscapular implants does not mediate estrogen-dependent dendrite growth, regardless of the 
site or mechanism of estrogenic regulation of BDNF in motoneurons.  It is possible that BDNF 
immunolabeling in SNB motoneurons is more sensitive to estradiol than dendritic morphology 
during this time, and interscapular estradiol implants cause an increase in estradiol levels that are 
high enough to alter somal BDNF via the SNB target muscle, but not high enough to mediate 
SNB dendrite growth.  However, BDNF immunolabeling in SNB motoneurons is comparable in 
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castrates treated with either interscapular estradiol or at the BC.  If somal BDNF is mediated by 
estradiol at the BC muscle, it would be expected that estradiol treatment at the BC muscle would 
elicit more robust changes in BDNF in SNB motoneurons than estradiol treatment in the 
interscapular region.  This further suggests that somal BDNF is not mediating the estrogen-
dependent dendrite growth, as similar levels of BDNF immunolabeling are found in SNB somata 
in both muscle and interscapular estradiol treatment, but only muscle-localized estradiol has an 
effect on SNB dendrogenesis. 
It is possible that the group differences in BDNF immunolabeling failed to reach 
significance due to small numbers of animals in each group (4-6).  However, robust, significant 
differences in BDNF immunolabeling in adult SNB motoneurons have been observed with similar 
numbers of animals (5-6) in each group, and there have been many demonstrations of significant 
group differences in motoneuron morphology (e.g., Rudolph and Sengelaub, 2013a; Rudolph and 
Sengelaub, 2013b) and BDNF protein (e.g., current chapter) using similar group numbers.  Based 
on these reasons, it is likely that the absence of significant group differences in BDNF 
immunolabeling in SNB motoneurons is a real effect, and not a statistical power issue. 
Given that there appears to be no difference in BDNF immunolabeling in response to 
castration or estradiol treatment during development, these results stand in contrast to the 
findings in adulthood that, in general, castration decreases BDNF immunolabeling and 
testosterone treatment restores BDNF immunolabeling to gonadally intact levels (Verhovshek et 
al., 2010a).  One explanation for the different pattern of results across developmental time points 
(P21 vs. adulthood) could be the time period between castration and assessment of BDNF 
immunolabeling.  No change in BDNF in SNB somata was observed two weeks after castration in 
early development, but an overall decrease in somal BDNF was measured three weeks post-
castration in adulthood.  It is possible that castration-induced changes in somal BDNF occur, but 
that this change requires more than two weeks (e.g., three weeks) to be detected using our 
immunohistochemical technique.  However, BDNF mRNA is altered in response to castration 
after only two weeks in adulthood (Ottem et al., 2007), suggesting that changes in somal BDNF 
levels can occur within a shorter period of time.  It is important to note that changes in BDNF 
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observed within two weeks of castration in adulthood occurred with BDNF mRNA, not BDNF 
protein, and it is important to note that alterations in mRNA versus protein do not always follow 
the same pattern or time course of changes (Solum and Handa, 2002), and we did not assess 
changes in BDNF mRNA.  Further, we have observed robust changes in BDNF levels in other 
components of the SNB neuromuscular system (i.e., BC muscle) during this development period 
two weeks post-castration.  Another possible explanation for the different pattern of changes 
observed in somal BDNF in the SNB after castration is that developmental and adult castration 
result in significantly different changes in gonadal hormones, depending on whether the 
procedure is performed during development or in adulthood.  At P7, serum testosterone levels 
are significantly lower (~0.6 ng/ml) than they are in adulthood (~3.5 ng/ml; Döhler and Wuttke, 
1975; Walker et al., 2012), so early castration results in a significantly smaller change in 
testosterone levels compared to adult castration.  If BDNF levels are sensitive to the magnitude of 
change in serum testosterone, it is possible that changes in BDNF would only occur when 
changes in circulating testosterone are large enough to elicit changes in BDNF (e.g., in 
adulthood). 
BDNF ELISA 
In this study, I found that BDNF levels in the BC muscle increase by 45% two weeks 
following castration.  These results replicate the findings from adulthood that demonstrate 
castration-induced increases in BC BDNF.  However, estradiol treatment (regardless of treatment 
location) had no effect on the castration-induced increases in muscle BDNF.  The failure of 
estradiol treatment to attenuate this increase in BDNF suggests that muscle BDNF, similar to 
somal BDNF, is not regulated by estrogens.  In adulthood, testosterone treatment fully prevents 
the castration-induced increase in muscle BDNF, demonstrating that peripheral BDNF levels are 
androgen-regulated in the SNB system.  We did not assess the ability of androgens to alter BDNF 
levels in the BC during development, so it is possible that BDNF levels in the BC are regulated by 
androgens, not estrogens during development. 
While early castration does not significantly alter BDNF immunolabeling in SNB somata, 
BDNF protein in the SNB target muscle increases significantly in response to castration on P7, 
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suggesting that early castration differentially alters BDNF in the SNB target muscle, but not in 
SNB somata.  One explanation for this could be a difference in androgen sensitivity of the SNB 
target muscle compared to SNB somata.  Neonatally, ARs are present in the BC muscle, but not 
in SNB motoneurons (Fishman et al., 1990).  Further, at P7, AR immunoreactivity in the SNB 
target muscle is not different from its adult levels.  In contrast, on P7, AR immunolabeling in SNB 
motoneurons is significantly lower than its adult levels (Jordan et al., 1997).  Given the 
relationship between AR density and androgen sensitivity (e.g., Huguenard et al., 2011), these 
data suggest that the BC muscle is more sensitive to androgens than SNB motoneurons on P7, 
when castrations were performed.  If BDNF levels in the SNB system are uniquely androgen 
sensitive during early development, the differential androgen sensitivity of the SNB target muscle 
compared to SNB somata explains why BDNF levels are altered by castration in the BC, but not 
somata.  However, in adulthood, the site of action for androgenic regulation of BDNF levels in 
SNB somata is the target muscle itself (Verhovshek and Sengelaub, 2013), suggesting that the 
AR density in the SNB target muscle, not the motoneurons, is the critical aspect for the regulation 
of BDNF in both central and peripheral components of the SNB system.  While it is unlikely that 
the site of action for regulation of BDNF in SNB motoneurons differs from development to 
adulthood, experiments to address this site of action in development should be performed. 
Another explanation for the potentially conflicting results could be a reflection of the 
differential sensitivity of the methods used to measure BDNF in somata versus muscle.  The 
immunolabeling technique used to assess BDNF in SNB motoneurons is semi-quantitative and 
reports optical density as a proxy for BDNF levels, whereas BDNF levels in the SNB target 
muscle were measured by ELISA, and levels of BDNF are reported as pg/mg, arguably, a much 
more sensitive measure of BDNF than immunolabeling optical density in SNB somata.  In 
adulthood, the castration-induced change in circulating testosterone levels is large, potentially 
eliciting a greater change in BDNF in the SNB neuromuscular system that is detectable by both 
immunolabeling and ELISA.  However, the much lower levels of circulating testosterone at P7, 
results in a smaller change in androgens following castration on P7, resulting in smaller changes 
in BDNF, which are detectable only by the more sensitive ELISA technique.  It is possible that 
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castration-induced increases in muscle BDNF protein could be the result of a general increase in 
peripheral protein production following castration.  However, there was no difference in overall 
protein levels in the BC group following castration, demonstrating that the changes observed in 
BDNF levels were due to changes in BDNF protein alone, and not to a general increase in BC 
muscle protein. 
Regardless of the reason for a differential regulation of BDNF in the peripheral and 
central components of the SNB system, it remains that BDNF levels increased in the SNB target 
muscle two weeks after early castration.  A post-castration increase in BDNF in the muscle could 
be explained by a decrease in retrograde transport of muscle-produced BDNF to SNB 
motoneuron.  The castration-induced increase in muscle BDNF could reflect a decrease in 
retrograde transport of BDNF from the BC/LA to SNB motoneurons or an increase in peripheral 
BDNF production in the absence of gonadal hormones.  Additionally, the site of action of BDNF 
regulation of SNB motoneuron morphology is unknown.  It is possible that muscle BDNF directly 
alters dendritic morphology via retrograde transport.  Alternatively, a change in BDNF in the 
muscle could be the initial step in a molecular cascade that ultimately alters the cellular 
composition of SNB motoneurons, and dendritic morphology could be regulated by molecular 
changes in the motoneurons.  Future studies should determine whether changes in dendritic 
morphology secondary to changes in muscle BDNF are controlled by muscle- or motoneuron-
localized events, and if they are directly regulated by BDNF or by secondary molecular pathways. 
Regardless of the mechanism, the castration-induced increase in muscle BDNF 
coincides with a failure of SNB dendrites to grow, suggesting that BDNF has an inhibitory role on 
SNB dendrites during early development.  In adulthood, blockade of BDNF using a trkB IgG alters 
SNB dendritic morphology and soma size (Verhovshek and Sengelaub, 2010), but this method of 
altering BDNF signaling has not been used developmentally to determine if there is a role for 
BDNF in the growth of SNB dendrites during the early postnatal period.  Given that BDNF is 
involved in the masculinization of SNB cell number (Xu et al., 2001), and changes in gonadal 
hormones during the first few postnatal weeks alters BDNF at the site of action for SNB dendrite 
growth (current chapter), future studies should determine if BDNF affects SNB motoneuron 
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morphology during early development as it does in adulthood by blocking BDNF signaling with 
trkB IgG. 
 
CONCLUSIONS 
In this chapter, I have demonstrated that early castration results in an increase in BDNF 
in the SNB target muscle, but no significant change in BDNF immunolabeling in SNB somata.  In 
both cases, estradiol treatment does not alter BDNF levels, suggesting that BDNF in peripheral 
and central components of the SNB system is not regulated by estrogens during the early 
postnatal period.  These data rule out a role for BDNF in the molecular mechanisms of estrogen-
dependent SNB dendrogenesis, and suggest that another molecular pathway is involved in 
mediating dendrite growth during this developmentally restricted critical period.  This is in contrast 
to the adult SNB system, in which androgens maintain SNB morphology through the modulation 
of BDNF.  Together, these data suggest that different molecular pathways underlie the estrogenic 
versus androgenic components of SNB dendritic growth and maintenance, respectively.  The 
molecular mechanisms of estrogen-dependent dendrogenesis remain to be determined, but 
candidate molecular pathways include estradiol regulation of insulin-like growth factor-I (Arevalo 
et al., 2012), or via a Src/Ras/ERK pathway (Miñano et al., 2008).  IGF-I and ERs colocalize in 
many nervous system structures (e.g., Garcia-Segura et al., 2010), and IGF-I has been shown to 
promote neuritogenesis in an ERα-dependent manner (e.g., Ma et al., 1994).  IGF-I and estradiol 
interact developmentally, and these interactions have been shown regulate features of neural 
development, including the differentiation of sexually dimorphic structures critical for 
neuroendocrine control of reproductive processes (Carrer and Cambiasso, 2002). 
It is possible that androgen- and estrogen-dependent dendrite growth during the early 
postnatal period are both mediated by a non-BDNF mechanism.  This would suggest that the 
mechanisms of dendritic growth are different than the mechanisms of maintenance of SNB 
dendritic morphology, as we know BDNF is involved in the regulation of SNB dendritic lengths in 
adulthood.  Further, this would indicate that molecular mechanisms of SNB dendrite growth are 
not hormone-specific, but temporal-specific, as early dendrite growth (either estrogen- or 
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androgen-dependent) could be mediated by a non-BDNF mechanism, whereas SNB dendritic 
maintenance is mediated by BDNF.  Experiments should be performed to determine if SNB 
dendrogenesis during early development occurs through one molecular pathway, regardless of 
which gonadal hormone is mediating the dendrite growth.  If the molecular pathway mediating 
SNB dendrogenesis is not conserved across gonadal hormones during early development, it 
remains possible that androgen regulation of SNB dendrites throughout the lifespan is mediated 
by BDNF, and estrogen regulation of SNB dendritic morphology occurs through a distinctly 
separate molecular pathway.  To answer these questions, future studies should assess 
androgenic regulation of BDNF during the early postnatal period in SNB motoneurons and their 
target muscles, and determine the effects of trkB IgG treatment on SNB motoneuron morphology 
during the early postnatal.  Additionally, studies should assess the molecular pathways (e.g., IGF-
I) mediating estrogen-dependent dendrite growth during early development. 
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CHAPTER 7: General Discussion 
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This dissertation has focused on identifying the mechanisms regulating the critical period 
for estrogen-dependent dendrite growth in the SNB.  I have demonstrated that estrogen-
dependent SNB dendrite growth occurs coincident with ERα expression in extra-muscle fiber 
cells of the SNB target muscle, and restricting estradiol treatment to the BC muscle during the 
period of maximal extra-fiber ERα expression results in full estrogen-dependent masculinization 
of SNB dendrites (Rudolph and Sengelaub, 2013a; Chapter 2).  In Chapter 3 I showed that ERα-
expressing extra-muscle fiber cells are regulated by early gonadal hormones, as castration 
results in an upregulation of ERα in the SNB target muscle (Rudolph and Sengelaub, 2013b).  
Further, brief estradiol treatment during the heightened ERα expression in the SNB target muscle 
results in rapid, robust dendritic growth, suggesting that extra-muscle fiber ERα density 
determines the estrogen sensitivity of SNB dendrites during early development.  Muscle ERα 
appears to have a role in determining the temporal limits of the critical period for estrogen-
dependent dendrogenesis as well.  In Chapter 4 I demonstrated that castration-induced 
upregulation of extra-fiber ERα in the BC permits estrogen sensitivity of SNB dendrites outside 
the typical critical period for dendritic growth in response to estrogens.  This was the first 
demonstration that SNB morphology can respond to estradiol treatment outside of the early 
postnatal period.  The first 3 experimental chapters have solidified the importance of extra-muscle 
fiber ERα in the SNB target muscle in estrogen-dependent SNB dendrite growth, both within and 
outside of the early postnatal period.  Chapter 5 ruled out satellite cells as the ERα-expressing 
extra-muscle fiber cells that appear to be the site of action for estrogen-dependent SNB dendrite 
growth.  In Chapter 6, I investigated the potential role of BDNF in estrogen-dependent dendrite 
growth, assessing BDNF in SNB motoneurons and their target muscles after castration and 
estradiol treatment.  The results from these experiments suggest that while peripheral BDNF is 
sensitive to castration, central BDNF is not.  Most importantly for this thesis, BDNF in either 
component of the SNB neuromuscular system is insensitive to estradiol treatment, indicating that 
BDNF does not mediate estrogen-dependent SNB dendrite growth. 
While this dissertation has answered many questions about the mechanisms of SNB 
dendrite growth in response to estrogens, a number of details about how estrogens promote SNB 
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dendrite growth remain unknown.  One of the most striking findings from this work was 
discovering that estrogen-dependent SNB dendrite growth could occur outside the early postnatal 
period.  Previously, SNB dendritic morphology was thought to be entirely estrogen-insensitive 
after P28, but I found that castration-induced maintenance of extra-fiber ERα in the BC permits 
dendrogenesis in response to estradiol treatment through P49.  What remains unclear is the 
duration of estrogen responsiveness of SNB dendrites after early castration.  We know that ERα 
is upregulated at P21 following gonadectomy on P7, and that treatment with estradiol from P28 to 
P49 results in typical dendritic lengths, but the time course and permanence of this ERα are 
unknown.  Previous work performed on non-sexually dimorphic rodent skeletal muscle has shown 
that castration-induced upregulation of muscle ERα occurs within 3 weeks, and as little as 48 
hours post-castration (Baltgavis et al., 2010).  The only post-castration time point used in the 
current work for measurements of muscle ERα levels in the BC was 2 weeks, but it is likely that 
the ERα upregulation occurred before this time point.  Given that during typical development, 
significant differences in BC extra-fiber ERα occur within 1 week, (the developmental 
downregulation of ERα from P14 to P21; Rudolph and Sengelaub, 2013a; Chapter 2), and in 
other skeletal muscles, ERα is upregulated 48 hours after castration (Baltgavis et al., 2010), it is 
likely that the increase in extra-fiber ERα following castration occurs earlier than 2 weeks.  Future 
studies should determine the time course of castration-induced changes in extra-muscle fiber 
ERα of the BC muscle, both during typical development (e.g., time points within the 1-week 
intervals from P7 to P28 when the developmental downregulation occurs) and following 
castration. 
In addition to determining the time course of developmental downregulation of extra-
muscle fiber ERα, the duration of extra-muscle fiber ERα upregulation following castration should 
be assessed.  In the current experiments, ERα was upregulated at P21 following castration on 
P7, and treatment with estradiol from P21 to P28 or P28 to P49 resulted in dendritic growth.  This 
suggests that the castration-induced upregulation is stable at the minimum from P21 to P28, 
because estradiol treatment beginning at P28 results in SNB dendrite growth by P49.  It is also 
possible that once upregulated via early castration, extra-muscle fiber ERα levels in the SNB 
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target muscle could remain stable indefinitely, creating an SNB system that is permanently 
estradiol sensitive.  Similar to understanding the duration of castration-induced ERα upregulation, 
future studies should investigate how this enhanced ERα expression responds to exogenous 
estradiol treatment.  It has been suggested that the typical downregulation of extra-muscle fiber 
ERα occurs due to high postnatal estradiol levels (Rudolph and Sengelaub, 2013a; Rudolph and 
Sengelaub, 2013b), and it is possible that exogenous estradiol treatment affects muscle ERα in a 
similar manner.  If estradiol treatment in castrates downregulates BC extra-muscle fiber ERα, the 
time course of this downregulation should be assessed to understand when during the treatment 
period ERα levels are reduced to a point where SNB dendrites are no longer able to respond to 
estradiol treatment with dendritic growth.  In P7 castrates, estradiol treatment from P21 to P28 
and P28 to P49 results in robust dendritic growth by P28 and P49, respectively, but it is not 
known when in these treatment periods dendritic growth occurs.  It is possible that SNB dendrites 
of P7 castrates respond on the first day of estradiol treatment with rapid, robust dendritic growth, 
and extra-muscle fiber ERα responds to this estradiol treatment by downregulating its receptor.  
In this scenario, the brief estradiol-ERα interaction at the muscle is sufficient to promote dendritic 
growth that persists through P28 and P49.  It is also possible that the castration-induced ERα in 
BC extra-muscle fiber cells is stable, and estradiol treatment (either from P21 to P28 or P28 to 
P49) promotes a steady rate of dendritic growth throughout the estradiol treatment period.  The 
time course of estradiol-dependent dendritic growth in P7 castrates treated with estradiol both 
during the early postnatal period and outside of this period should be assessed. 
Another unanswered question that remains concerns the molecular mechanisms 
mediating estrogen-dependent SNB dendrite growth.  In Chapter 6, I concluded that BDNF is not 
involved in estrogen-mediated dendrogenesis during the early postnatal period, and suggested 
that estrogens could be regulating other molecular messengers (e.g., IGF-I) to modulate dendritic 
morphology.  These examples involve the classical actions of estradiol: receptor binding followed 
by translocation to the cell nucleus where the receptor-hormone complex acts as a transcription 
factor to regulate gene expression.  However, recent advances in the understanding of estrogenic 
modulation of the morphology of neural structures that control sexually dimorphic behaviors 
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suggest that ERα could direct changes in cellular morphology via its actions at the cell surface 
(reviewed in Micevych and Christensen, 2012).  In the hypothalamus, neurons in the arcuate 
nucleus that regulate lordosis undergo rapid, significant changes in dendritic spine morphology in 
response to estrogens acting through membrane receptors (Christensen et al., 2011).  The 
membrane-localized effects of estradiol often require ER interaction with metabotropic glutamate 
receptors (mGluRs; reviewed in Boulware and Mermelstein, 2009), and ER-mGluR interactions 
have been shown to alter dendritic morphology resulting in changes in sexual behavior, including 
lordosis (Christensen et al., 2011).  Importantly, estradiol effects on skeletal muscle have been 
shown to be mediated by membrane ERα (Galluzzo et al., 2009; Hatae et al., 2009), suggesting 
that estradiol action at ERα-expressing extra-muscle fiber cells could be occurring at the cell 
surface.  Future studies should assess the potential for membrane-bound ERα to regulate 
estrogen-dependent SNB dendrite growth during the early postnatal period. 
In adulthood, the mechanism sustaining SNB dendritic lengths is known: BDNF mediates 
the androgen-dependent maintenance of SNB dendritic morphology, but it is unclear what the 
mechanism is that mediates the androgen component of dendritic growth during development.  
Given that BDNF blockade perinatally affects the androgen-dependent regulation of SNB cell 
number (Xu et al., 2001), there is a clear role for BDNF in SNB motoneuron development.  BDNF 
blockade in adulthood affects not only SNB dendritic lengths, but soma size as well (Verhovshek 
and Sengelaub, 2010) demonstrating that the androgen-dependent effects of BDNF on SNB 
motoneurons occurs both developmentally and in adulthood.  Therefore, it is likely that BDNF 
plays a role in SNB dendrite growth during development, potentially through androgen-mediated 
pathways.  Future studies should determine if BDNF mediates the androgen component of SNB 
dendrite growth during the early postnatal period to address the possibility that the androgen-
dependent growth and retraction of SNB dendrites occurs through a conserved molecular 
pathway. 
The convergence of two molecular pathways mediating dendritic growth, one via 
estrogens and one via androgens, could explain the pattern of dendritic growth (P7-P28; 
Goldstein and Sengelaub, 1994) and retraction (P28-P49; Goldstein et al., 1990) that occurs in 
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the SNB during development.  If androgens and estrogens both promote dendrite growth (via 
distinct pathways) through P28, this could explain the robust dendritic growth that occurs from P7 
to P28.  At P28, due to the downregulation of extra-muscle fiber ERα, estrogens lose their 
effectiveness in promoting dendrogenesis.  When the SNB becomes insensitive to estrogens, the 
remaining effect of gonadal hormones on dendrogenesis is androgenic, and given the low, 
prepubertal levels of androgen, dendrites retract to their adult lengths (Goldstein et al., 1990).  
This dual process model of SNB dendritic growth and maintenance explains why SNB dendritic 
growth is only partial when either estradiol or dihydrotestosterone alone is supplied during 
development (Goldstein and Sengelaub, 1994), but when combined fully support SNB dendrite 
growth through P28 (Burke et al., 1997).  Additionally, this model accounts for why SNB dendrite 
growth is incomplete with fadrozole treatment: this aromatase blockade eliminates the estradiol 
component of SNB dendrite growth (Burke et al., 1999).  These data support the idea of a dual 
process model in which androgens and estrogens act through different molecular mechanisms to 
regulate SNB dendrogenesis.  To fully understand how androgens and estrogens mediate this 
SNB dendritic growth during development, the molecular mechanisms of androgen- and 
estrogen-dependent SNB dendrite growth must be determined. 
Estrogen-dependent SNB dendrite growth is mediated by extra-fiber ERα in the SNB 
target muscle, and SNB dendrites become insensitive to estrogens when ERα is downregulated 
in the BC muscle.  The mechanism of developmental downregulation of extra-muscle fiber ERα is 
unknown, but gonadal hormones are involved in this process, as early castration prevents the 
typical downregulation of ERα in the muscle.  Previous work has demonstrated that estradiol can 
downregulate ERα, in skeletal muscle (Baltgavis et al., 2010) and in a variety of structures across 
the neuraxis (e.g., Shughrue et al., 1992; Sohrabji et al., 1994).  Estradiol levels are very high 
during the early postnatal period (Döhler and Wuttke, 1975), suggesting that estradiol-induced 
downregulation of ERα in the BC is possible.  More recent findings indicate that this estradiol-
dependent regulation of ERα could be occurring through changes in DNA methylation patterns 
(reviewed in Imamura, 2011).  Indeed, ERα promoter regions have been shown to be 
downregulated by estradiol (Saceda et al., 1988), potentially via changes in DNA methylation.  
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Once established, DNA methylation patterns can be quite stable, allowing for estradiol-dependent 
changes in methylation of promoter regions of ERα to maintain ERα expression at low levels after 
downregulation has occurred during the early postnatal period.  Removal of estradiol via 
castration would eliminate any estradiol-dependent changes in DNA methylation, preventing the 
downregulation of muscle ERα and resulting in estrogen sensitive SNB dendrites outside the 
early postnatal period.  This provides a mechanism for how early gonadal hormone exposure 
establishes the transient pattern of estrogen sensitivity observed in the SNB system.  Future 
studies should determine if the developmental downregulation of extra-muscle fiber ERα occurs 
through estrogen-dependent changes in DNA methylation patterns.  The stability of these 
methylation patterns should be assessed in order to understand the potential permanence of the 
castration-induced upregulation of ERα.  In conclusion, this thesis has examined many 
mechanisms of estrogen-dependent SNB dendrite growth, including the role of extra-muscle fiber 
ERα, the sensitivity of extra-fiber ERα to early gonadal hormone exposure and the relationship of 
changes in ERα to estrogen sensitivity of SNB dendrites, and the potential role of BDNF in 
estrogen-dependent dendrite growth.  This research has provided valuable insights into the 
understanding of estrogen-mediated differentiation of sexually dimorphic neuromuscular system, 
and future studies should build upon these results to fully understand not only the complete set of 
mechanisms of estrogen-dependent dendrite growth, but how androgens and estrogens interact 
developmentally to direct the growth and retraction of SNB dendrites. 
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